
================================================================================
Date: 2024-10-26 17:43
Type: PEDIATRIC PHYSICIAN PROGRESS NOTE
Author: ALTAMIMI,DINA HATEM IZZELDEEN ALKHA
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
--------------------------------------------------------------------------------

                         Pediatric Physicians Progress note

--------------------------------------------------------------------------------

----------------Subjective---------------

 

- Respiratory: no cough , No chest pain

- Gastrointestinal: no Abdominal pain, No change in bowel habits, No vomiting

- Genitourinary: No dysuria, No change in urine color or smell

- Musculoskeletal: No joint pain, swelling or redness, No limping.

- Skin: Normal, No skin rash, No easy bruisability. 

- Neurological: No headache, No abnormal movement.

 

----------------Objective----------------

 

- Cardiovascular: Normal S1, S2, No murmurs or added sounds.

- Respiratory: Normal air entry, no added sounds, Normal chest expansion.

- Gastrointestinal: Soft lax abdomen, No Tenderness, Normal bowel sounds.

- Musculoskeletal: No swelling or redness, No limping,

- Skin: no skin rash nor redness

- Neurological: Active, Normal power, No weakness, No abnormal reflexes.

                Reactive pupils, no nystagmus

 

----------------Last Vital signs---------

 

   DATE/TIME         TEMP    PULSE   RESP    BP      PAIN    WT (LB) P OX 

10/26/24 @ 1700     98.8    129     23      108/64                  99 

10/26/24 @ 1527                                             82.01 

10/26/24 @ 1303     98.1    110     23      112/70                  99 

10/26/24 @ 0850     98.4    118     23      114/73                  99 

10/26/24 @ 0425     97.9    112     24      108/61                  99 

10/26/24 @ 0027     98.1    100     24      106/58                  98 

Pain Score:  0 No pain

 

----------------Intake/output------------

 

Not calculated. 

 

---------------Most recent lab-----------

 

PROTHROMBIN TIME: 13.1 

PARTIAL THROMBOPLASTIN TIME: 29.7 

INR: 0.98 

 

GLUCOSE: 91.80 

CREATININE: 0.4 

SODIUM: 136.70 

POTASSIUM: 4.13 

CHLORIDE: 105.90 

CALCIUM: 9.10 

PO4: 4.02 

URIC ACID: 3.00 

ALBUMIN: 4.0 

BILIRUBIN,TOTAL: 0.27 

ALKALINE PHOSPHATASE: 125.000  L

SGOT: 28.60 

MAGNESIUM: 2.44 

BICARBONATE: 16.4  L

ALANINE AMINO TRANSFERASE: 314.0  H

BILIRUBIN DIRECT,SERUM LEVEL: 0.12 

PROTEIN(SERUM): 6.8 

UREA SERUM LEVEL: 38.60  H

ADJUSTED CALCIUM: 9.08 

 

WBC: 5.90 

PLT: 50  L

LYMPHS: 51.0  H

MONOCYTES: 4.0 

HB (HGB): 12.1 

NEUTROPHIL: 44.8 

NEUTROPHILS#: 2.6 

 

- Cultures: 

  blood culture 19/10: no growh 

  blood culture 17/10: no growth

  stool culture 17/10: negative

 

----Radiology during current admission---

 

- Brain CT scan with contrast 15/10 : 

No intracranial haemorrhage, midline shift or herniation. Patent dual venous 

sinuses 

 

- Brain MRI 17/10 : Cranial nerve thickening with enhancement, along with 

involvement of the cavernous sinus structures, the pituitary stalk and the 

pharyngeal space. Finding are likely representing leukemic infiltration.

 

- Renal Doppler U/S 17/10 : Hepatosplenomegaly with liver span 14 cm and spleen 

span 14.6 cm. Unremarkable normal renal Doppler scan, no signs of renal artery 

stenosis.

 

- Abdominal U/S 22/10 : MILD HEPATOMEGALY 

 

------------------Consults---------------

 

None

 

-----------------Medications-------------

 

- Oral and anal care

- Keppra

- Diamox

- Amlodipine

- Loratidine

- Propranolol

- Lansoprazole

- Pracetamol

- Bactrim as prophylxis

- Gabapentin 300*2

- Dexamtheasone 4*2

 

----------------Active Problems----------

 

 1. Leukemia, Lymphocytic  Acute, B-cell  Low Risk   EOI : negative MRD

 2. Syrian refugee  lives in refugee camp 

 3. sever vomiting after anesthesia 

 4. delayed MTX excretion

 5. Pancytopenia  Recurrent Anemia

 6. septic shock ICU admission 

 7. TBNK flow: low

 8. chemosensitivity for workup

 9. Suspected relapse

10. Papilledema 

11. Overweight

 

----------Assesment and Plan of care-----

 

- Z**********er Al-********** is an ********** Year old girl a case of low risk B cell ALL

- status post: off therapy on 12/12/2023

- Admitted as case of combined relapse B-ALL on 16/10

- Transferred to ICU 17-23/10 for elevated blood pressure readings, transferred 

  back to floor on 23/10.

 

In ER:

=========================================================================

on 15/10:

---------

- she presented to ER with headache since 1 month that got 

worse today associated with photophobia and unsteady gait. She also has polyurea

 

but no vomiting ,no abdominal pain. 

Afebrile 

- she was found to be hypertensive.

Brain CT was done:No intracranial 

haemorrhage, midline shift or herniation, Petent dual venous sinuses.

- she was given hydralazine and nephrology consulted :no need to start 

antihypertensive medication to follow up in clinic 

- peripheral flow was sent showed: 8 % blast

 

on 16/10:

--------

- re-presented to ER with same complaint. 

 

on exam:

- there is sluggish left pupil , limitation in eye movement , multidirectional 

nystagmus , wide based gait , ataxic , can't do tandem gait 

 

 

consults:

---------

- Opthalmology -> left eye exotropia + limitation on adduction , 

                  has papilledema- treat her increased ICP- 

                  do Brain + Orbit Mri to rule out brain versus orbital 

                  leukemic infiltrtaion is needed

                  diamox dose + steroid is recommended to decrease 

                  intracranial pressure utill the underlying cause resolve 

 

- Nephrology consulted -> start on amlodipine 2.5mg Qday 

Renal Doppler U/S 17/10 : Hepatosplenomegaly with liver span 14 cm and spleen 

span 14.6 cm. Unremarkable normal renal Doppler scan, no signs of renal artery 

stenosis.

 

Medications:

------------

-recieved perflgan , Hydralazine and dexamethasone 4 mg

 => her headache improved 

 

 

Labs:

-----

- CBC: hemoglobin 13.3 , WBC 6.6 , platlets 97 , ANC 2400

- Chesmitry : normal

 

so she was admitted to floor on keppra 300 mg*2, diamox 250mg*2 , amlodipine 

2.5mg Qday

 

Brain and orbit MRI done after admission : FREE AS PRIMARY READING

 

Floor 17/10:

==================================================================

-last night she recived 2 hydralazine for high blood pressure reading

-persinstantly hypertensive regardless hydralazine ( 140s/100s)

-renal ultrasound:

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

so transferred to PICU to manage high blood pressure reading on 17/10.

 

ICU 17-23/10

==================================================================

oncology: 

---------

17/10 :

- started on dexamethasone PO 8mg/m2

- has combined relapse:

Bone marrow biopsy showed : 70% blasts 

triple IT given , LP done : CNS +

- chemotherapy and 2nd triple IT held due to transaminitis

- Has left eye exotropia + limitation on adduction , bilateral papilledma 

 

MRI 16/10: optic nerve swelling. 

 

 

Respiratory:

------------

- ON room air  , normal oxygen saturation

- Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

Cardiovascular:

---------------

- 17/10 : echo : mild mitral valve prolapse with no MR (benign )

 

- 20/10 : developed SVT twice and received one dose of adenosine 

          and Dr. ********** **********h added Inderal 10 mg BID , did not re-occur.

 

- Heart rate 100-220

 

- Normal capillary refill

- LINE : periphral 

 

 

Nephrology:

-----------

Blood pressure 100-120/60-70 (95th centile)= 116/77

 

Controlled on :

- Hydralazine 0.2mg/kg/dose q4h prn 

- amlodipine 2.5 mg q24h 

- Inderal 10 mg *3  for SVT

 

Last :

- urine output : 2.5 ml/kg/hr

- balance:-140 ml

 

Renal doppler U/S 17/10 :

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

 

Central nervous system:

-----------------------

- CONSCIOUS , ALERT ORIENTED 

- GCS : 15/15 

- left eye exotropia (improved)

 

ON :

paracetamol oral PRN 

gabapentin  300MG ORAL BID 

Keppra      300MG   BID 

Diamox      250MG PO Q12H 

 

- brain ct scan with contrast 15/10 : unremarkable 

- brain MRI 17/10 : optic nerve swelling 

 

Gastrointestinal:

-----------------

- She has rising transaminases (ALT>AST) with normal bilirubin and normal 

coagulation profile, glucose, and albumin

 

Trend : 17/10 (167/152) -> 21/10 (711/432) -> 22/10 (954/234)

        -> 23/10 (895/234) >25/10 (416/37)

 

- Clinically she has hepatomegaly without tenderness. No jaundice. 

 

- Liver U/S 22.Oct.2024: hepatosplenomegaly with no focal lesion 

 

- Exam : SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

On :

- low bacterial diet 

- nexium 

- IV fluid maintenance 

 

ABDOMINAL U/S 22/10 : MILD HEPATOMEGALY 

 

 

Infectious disease:

--------------------

for persisntent tacycardia , septic workup and was started on tazocin and 

amikacin then after 3 days upgraded into meropenem and vancomycin then after 2 

days downgraded into cefepime for 3 days

 

- remained afebrile, currently off antibiotics

 

ON: 

Prophylaxis : Bactrium 

 

Cultures:

-blood culture 19/10: free 

-blood culture 17/10 : free

-stool culture 17/10 : Negative for Salmonella and Shigella 

 

- CMV PCR POSITIVE : 789 

 

Floor:

======

Patient was treansferred back to the floor on 24/10 after stabilizing blood 

pressure readings.

 

Infectious:

----------

Afebrile off antibiotics.

On prophylactic bactrim.

 

Gastrointestinal:

-----------------

LFTS 17/10 (167/152) -> 21/10 (711/432) -> 22/10 (954/234)

     -> 23/10 (895/234) ->25/10 (416/37)

 

Lipid profile: 

CHOLESTEROL: 252.00 

TRIGLYCERIDE: 299.00  H

HDL: 43.90 

LDL CHOLESTEROL: 148  H

 

Hematology-oncology:

--------------------

 

- On dexamethasome 4*2

-  Had 2 TIT's

   First one on 17/10: complicated by transaminitis. Many blasts seen in 

   cytology

   Second one on 18/10: was given without MTX 

 

- Took Doxorubicin today and Vincristine on 25/10

 

Pain wise:

----------

No pain today.

On Gabapentin 300*2

 

Nephrology:

----------

Stable blood pressure readings:

On: amlodipine  2.5 mg q24h 

 

Cardiology:

-----------

SVT twice on 20/10

On: Inderal 10 mg *3  for SVT

 

Neurology:

----------

On: 

Keppra 300MG BID 

Diamox 250MG PO Q12H 

 

PLAN :

=======

- Observe blood pressure readings 

- Follow up on LFT

- Port placement tomorrow

- PEGasparginase tomorrow. 

 

------------Nutrition/Diet Plan----------

 

Low bacterial

 

------------VTE prophylaxis Plan---------

 

Patient Age < 10 years: NA

 

=================================Discharge planning note========================

Reason of admission: 

Relapse B-ALL for treatment

 

Estimated length of stay:

2 weeks

 

Goals of Care/needed interventions:

IV antibiotics, Chemotherapy

 

Special Needs upon Discharge

No Special needs

 

Delayed discharge

No




================================================================================
Date: 2024-10-26 16:27
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: ALMASAEID,BAYAN MUSALLAM HAJHOUJ
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:21    BA                     ALL-RELAPS  behavior change,       

                                             ataxia                             

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     na                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-26 08:21    BA                                            36.70 (kg)  

  2024-10-26 15:27    AS                                            82.01 (lb)  

     Comment: Data retrieved from VistA Vitals Package

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:24    BA                     25/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     bone                               

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     Throb                              

  2024-10-26 08:00    BA                     Sharp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     SUDDEN ONSET                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     analgesia                          

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     paracetamol 10 mg/ml               

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     PRN                                

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     PARACETAMOL TAB 500 mg po bid      

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     GABAPENTIN CAP,ORAL  300 mg        

                                             po bid                             

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     0=Alert                            

  2024-10-26 12:00    BA                     0=Alert                            

  2024-10-26 16:00    BA                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-26 08:00    BA                     NA                                 

  2024-10-26 12:00    BA                     NA                                 

  2024-10-26 16:00    BA                     NA                                 

 

 

 

 

 




================================================================================
Date: 2024-10-26 06:31
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: AL-HALAPI,TAMARA AREF FATHI
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 19:43    TA                     ALL-Relapse                        

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     no                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-25 19:43    TA                                            36.70 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 19:47    TA                     24/10                              

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     bone                               

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     FLACC                              

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     Throb                              

  2024-10-25 20:00    TA                     Sharp                              

  2024-10-25 20:00    TA                     Stab                               

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     SUDDEN ONSET                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     na                                 

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     analgesic                          

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     gab300 BID                         

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     Gabapenthin 300 po BID             

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 20:00    TA                     0                                  

  2024-10-26 00:00    TA                     0                                  

  2024-10-26 04:00    TA                     0                                  

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 




================================================================================
Date: 2024-10-25 17:37
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: ALMAJALI,RAHAF RAAD ZAID
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     all-relaps                         

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-25 07:00    RA                                            36.20 (kg)  

  2024-10-25 14:37    AS                                            80.91 (lb)  

     Comment: Data retrieved from **********istA Vitals Package

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     24/10                              

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     headche                            

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     Sharp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     medication                         

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     GABAPENTIN CAP,ORAL 300MG          

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 07:00    RA                     GABAPENTIN CAP,ORAL 300MG          

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 08:00    RA                     0                                  

  2024-10-25 12:00    RA                     0                                  

  2024-10-25 16:00    RA                     0                                  

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 08:00    RA                     0=Alert                            

  2024-10-25 12:00    RA                     0=Alert                            

  2024-10-25 16:00    RA                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-25 08:00    RA                     NA                                 

  2024-10-25 12:00    RA                     NA                                 

  2024-10-25 16:00    RA                     NA                                 

 

 

 

 

 

 

 




================================================================================
Date: 2024-10-25 14:16
Type: PEDIATRIC PHYSICIAN PROGRESS NOTE
Author: ALKHADER,TASNEEM KAMEL MOHAMMAD
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
--------------------------------------------------------------------------------

                         Pediatric Physicians Progress note

--------------------------------------------------------------------------------

 

- Zaher **********-********** is an ********** Year old girl a case of low risk B cell ALL

- status post: off therapy on 12/12/2023

- Admitted as case of combined relapse B-ALL on 16/10

- Transferred to ICU 17-23/10 for elevated blood pressure readings, transferred 

  back to floor on 23/10.

 

----------------Subjective---------------

 

- No Fever, Active, doing well, Good oral intake 

- Respiratory: no cough , No chest pain

- Gastrointestinal: NO Abdominal pain, No change in bowel habits, No vomiting

- Genitourinary: No dysuria, No change in urine color or smell

- Musculoskeletal: No joint pain, swelling or redness, No limping.

- Skin: Normal, No skin rash, No easy bruisability. 

- Neurological: No headache, No abnormal movement.

 

----------------Objective----------------

 

- Cardiovascular: Normal S1, S2, No murmurs or added sounds.

- Respiratory: Normal air entry, no added sounds, Normal chest expansion.

- Gastrointestinal: Soft lax abdomen, No Tenderness, Normal bowel sounds.

- Musculoskeletal: No swelling or redness, No limping,

- Skin: Normal, No skin rash, No easy bruisability. 

- Neurological: Active, Normal power, No weakness, No abnormal reflexes.

                Slugish pupils 

 

----------------Last Vital signs---------

DATE/TIME         TEMP    PULSE   RESP    BP      PAIN    WT (LB) P OX 

10/25/24 @ 1230     98.1    105     24      101/67                  100 

10/25/24 @ 0900     97.7    100     24      117/60                  100 

10/25/24 @ 0449     97.9    99      24      100/61                  98 

10/25/24 @ 0039     97.7    102     24      115/72                  99 

10/24/24 @ 2157     97.5    103     24      102/59                  99 

10/24/24 @ 1700     97.7    105     22      104/61                  98 

10/24/24 @ 1145     98.2    108     22      115/71                  99 

10/24/24 @ 1103     97.9    105     22      110/70                  99 

10/24/24 @ 0900     98.1    105     22      107/72                  99 

10/24/24 @ 0355     98.1    104     22      120/74                  99 

10/24/24 @ 0004     98.2    123     24      122/70                  99 

Pain Score:  0 No pain

 

----------------Intake/output------------

Not calculated 

 

---------------Most recent lab-----------

CHEMISTRY PROFILE-20 LIGHT GREEN PLASMA SP ONCE LB #**********24829

Collection time:          Oct 25, 2024@01:19:02

Test Name                 Result    Units           Range

GLUCOSE                     93.50      mg/dL Ref: Fasting: <110, Random: > or =1

 

year: 70-140 mg/dL, Diabetic:> 200

CREATININE                    0.5      mg/dL        .22 - .9

SODIUM                     137.00      mmol/L      135 - 145

POTASSIUM                    4.07      mmol/L      3.6 - 5.2

CHLORIDE                   108.50      mmol/L     98.6 - 111

CALCIUM                      8.74 L    mg/dL        9 - 10.5

PHOSPHORUS                   3.87      mg/dL       3.1 - 5.4

URIC ACID                    3.20      mg/dL       2.5 - 5.9

ALBUMIN                       3.8      g/dL        3.6 - 5.3

BILIRUBIN TOTAL              0.38      mg/dL         .2 - .8

ALKALINE PHOSPHATASE      129.000 L    U/L         130 - 335

AST/ASPARTATE AMINOTRANSFERASE  37.40  U/L            8 - 48

MAGNESIUM                    2.27      mg/dL       1.7 - 2.6

BICARBONATE                  14.0 L    mmol/L        21 - 28

ALT / ALANINE AMINOTRANSFERASE  416.0H U/L        7.2 - 21.2

BILIRUBIN DIRECT             0.14      mg/dL      0.01 - 0.3

TOTAL PROTEIN                 6.5      g/dL        6.2 - 8.2

UREA                        51.90 H    mg/dL         15 - 38

ADJUSTED CALCIUM             8.88 L    mg/dL        9 - 10.5

COMPLETEBLOOD COUNT WITH DIFFERENTIAL EDTA TUBE BLOOD SP ONCE LB #**********24829

Collection time:          Oct 25, 2024@01:18:55

Test Name                 Result    Units           Range

WBC                          6.70      10'3/ul     4.5 - 13.5

RBC                          4.09      10'6/ul        4 - 5.4

MCV                          84.3      fl            80 - 94

MCH                          28.9      pg            26 - 32

MCHC                         34.3      g/dl          32 - 36

RDW                          15.2 H    %         11.6 - 14.6

PLATELET COUNT,BLOOD           67 L    10'3/ul      150 - 400

MPV                           7.4 L    fl          7.5 - 9.3

LYMPHOCYTES%                 53.7 H    %             25 - 40

MONOCYTES%                    4.8      %              2 - 11

EOSINOPHIL%                   0.1 L    %               1 - 4

BASOPHIL%                     0.1      %               0 - 1

Hb                           11.8 L    g/dl          12 - 15

NEUTROPHILS%                 41.3      %             35 - 65

PCV                          34.5 L    %             35 - 49

NEUTROPHILS#                  2.8      10'3/uL      1.9 - 8.6

LYMPHOCYTES#                  3.6      10'3/uL        1 - 7.3

MONOCYTES#                    0.3 L    10'3/uL       .4 - 1.1

EOSINOPHILS#                  0.0      10'3/uL         0 - .2

BASOPHILS#                    0.0      10'3/uL         0 - .2

 

- Cultures: 

  blood culture 19/10: pending 

  blood culture 17/10: no growth

  stool culture 17/10: negative

 

----Radiology during current admission---

 

- Brain CT scan with contrast 15/10 : 

No intracranial haemorrhage, midline shift or herniation. Patent dual venous 

sinuses 

 

- Brain MRI 17/10 : Cranial nerve thickening with enhancement, along with 

involvement of the cavernous sinus structures, the pituitary stalk and the 

pharyngeal space. Finding are likely representing leukemic infiltration.

 

- Renal Doppler U/S 17/10 : Hepatosplenomegaly with liver span 14 cm and spleen 

span 14.6 cm. Unremarkable normal renal Doppler scan, no signs of renal artery 

stenosis.

 

- Abdominal U/S 22/10 : MILD HEPATOMEGALY 

 

------------------Consults---------------

- Opthalmology -> left eye exotropia + limitation on adduction , 

                  has papilledema- treat her increased ICP- 

                  do Brain + Orbit Mri to rule out brain versus orbital 

                  leukemic infiltrtaion is needed

                  diamox dose + steroid is recommended to decrease 

                  intracranial pressure utill the underlying cause resolve 

 

- Nephrology consulted -> start on amlodipine 2.5mg Qday 

 

-----------------Medications-------------

paracetamol oral PRN 

gabapentin  300MG ORAL BID 

 

Keppra      300MG   BID 

Diamox      250MG PO Q12H 

 

amlodipine  2.5 mg q24h 

Inderal     10 mg *3  for SVT

 

Bactrim prophylaxis

 

Histal

 

Dexamethasone 4 mg BID

Lansoprazole

Oral anal

 

----------------Active Problems----------

Active problems - Computerized Problem List is the source for the following:

 

 1. Leukemia, Lymphocytic  Acute, B-cell  Low Risk   EOI : negative MRD

 2. Syrian refugee  lives in refugee camp 

 3. sever vomiting after anesthesia 

 4. delayed MTX excretion

 5. Pancytopenia  Recurrent Anemia

 6. septic shock ICU admission 

 7. TBNK flow: low

 8. chemosensitivity for workup

 9. Suspected relapse

10. Papilledema 

 

----------Assesment and Plan of care-----

- Zaher **********-********** is an ********** Year old girl a case of low risk B cell ALL

- status post: off therapy on 12/12/2023

- Admitted as case of combined relapse B-ALL on 16/10

- Transferred to ICU 17-23/10 for elevated blood pressure readings, transferred 

  back to floor on 23/10.

 

In ER:

=========================================================================

on 15/10:

---------

- she presented to ER with headache since 1 month that got 

worse today associated with photophobia and unsteady gait. She also has polyurea

 

but no vomiting ,no abdominal pain. 

Afebrile 

- she was found to be hypertensive.

Brain CT was done:No intracranial 

haemorrhage, midline shift or herniation, Petent dual venous sinuses.

- she was given hydralazine and nephrology consulted :no need to start 

antihypertensive medication to follow up in clinic 

- peripheral flow was sent showed: 8 % blast

 

on 16/10:

--------

- re-presented to ER with same complaint. 

 

on exam:

- there is sluggish left pupil , limitation in eye movement , multidirectional 

nystagmus , wide based gait , ataxic , can't do tandem gait 

 

 

consults:

---------

- Opthalmology -> left eye exotropia + limitation on adduction , 

                  has papilledema- treat her increased ICP- 

                  do Brain + Orbit Mri to rule out brain versus orbital 

                  leukemic infiltrtaion is needed

                  diamox dose + steroid is recommended to decrease 

                  intracranial pressure utill the underlying cause resolve 

 

- Nephrology consulted -> start on amlodipine 2.5mg Qday 

Renal Doppler U/S 17/10 : Hepatosplenomegaly with liver span 14 cm and spleen 

span 14.6 cm. Unremarkable normal renal Doppler scan, no signs of renal artery 

stenosis.

 

Medications:

------------

-recieved perflgan , Hydralazine and dexamethasone 4 mg

 => her headache improved 

 

 

Labs:

-----

- CBC: hemoglobin 13.3 , WBC 6.6 , platlets 97 , ANC 2400

- Chesmitry : normal

 

so she was admitted to floor on keppra 300 mg*2, diamox 250mg*2 , amlodipine 

2.5mg Qday

 

Brain and orbit MRI done after admission : FREE AS PRIMARY READING

 

Floor 17/10:

==================================================================

-last night she recived 2 hydralazine for high blood pressure reading

-persinstantly hypertensive regardless hydralazine ( 140s/100s)

-renal ultrasound:

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

so transferred to PICU to manage high blood pressure reading on 17/10.

 

ICU 17-23/10

==================================================================

oncology: 

---------

17/10 :

- started on dexamethasone PO 8mg/m2

- has combined relapse:

Bone marrow biopsy showed : 70% blasts 

triple IT given , LP done : CNS +

- chemotherapy and 2nd triple IT held due to transaminitis

- Has left eye exotropia + limitation on adduction , bilateral papilledma 

 

MRI 16/10: optic nerve swelling. 

 

 

Respiratory:

------------

- ON room air  , normal oxygen saturation

- Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

Cardiovascular:

---------------

- 17/10 : echo : mild mitral valve prolapse with no MR (benign )

 

- 20/10 : developed SVT twice and received one dose of adenosine 

          and Dr. ********** **********h added Inderal 10 mg BID , did not re-occur.

 

- Heart rate 100-220

 

- Normal capillary refill

- LINE : periphral 

 

 

Nephrology:

-----------

Blood pressure 100-120/60-70 (95th centile)= 116/77

 

Controlled on :

- Hydralazine 0.2mg/kg/dose q4h prn 

- amlodipine 2.5 mg q24h 

- Inderal 10 mg *3  for SVT

 

Last :

- urine output : 2.5 ml/kg/hr

- balance:-140 ml

 

Renal doppler U/S 17/10 :

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

 

Central nervous system:

-----------------------

- CONSCIOUS , ALERT ORIENTED 

- GCS : 15/15 

- left eye exotropia (improved)

 

ON :

paracetamol oral PRN 

gabapentin  300MG ORAL BID 

Keppra      300MG   BID 

Diamox      250MG PO Q12H 

 

- brain ct scan with contrast 15/10 : unremarkable 

- brain MRI 17/10 : optic nerve swelling 

 

Gastrointestinal:

-----------------

- She has rising transaminases (ALT>AST) with normal bilirubin and normal 

coagulation profile, glucose, and albumin

 

Trend : 17/10 (167/152) -> 21/10 (711/432) -> 22/10 (954/234)

        -> 23/10 (895/234) >25/10 (416/37)

 

- Clinically she has hepatomegaly without tenderness. No jaundice. 

 

- Liver U/S 22.Oct.2024: hepatosplenomegaly with no focal lesion 

 

- Exam : SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

On :

- low bacterial diet 

- nexium 

- IV fluid maintenance 

 

ABDOMINAL U/S 22/10 : MILD HEPATOMEGALY 

 

 

Infectious disease:

--------------------

for persisntent tacycardia , septic workup and was started on tazocin and 

amikacin then after 3 days upgraded into meropenem and vancomycin then after 2 

days downgraded into cefepime for 3 days

 

- remained afebrile, currently off antibiotics

 

ON: 

Prophylaxis : Bactrium 

 

Cultures:

-blood culture 19/10: pending 

-blood culture 17/10 : free

-stool culture 17/10 : Negative for Salmonella and Shigella 

 

- CMV PCR POSITIVE : 789 

 

Floor:

==============================================================

Patient was treansferred back to the floor on 24/10 after stabilizing blood 

pressure readings.

 

Infectious:

----------

Afebrile off antibiotics.

On prophylactic bactrim.

 

Gastrointestinal:

-----------------

LFTS 17/10 (167/152) -> 21/10 (711/432) -> 22/10 (954/234)

     -> 23/10 (895/234) ->25/10 (416/37)

 

Lipid profile: 

CHOLESTEROL: 252.00 

TRIGLYCERIDE: 299.00  H

HDL: 43.90 

LDL CHOLESTEROL: 148  H

 

Hematology-oncology:

--------------------

- Labs:

  Hemoglobin: 11.8

  WBC: 6.7

  Platelets: 67

  ANC: 2800

 

- On dexamethasome 4*2

-  Had 2 TIT's

   First one on 17/10: complicated by transaminitis. Many blasts seen in 

   cytology

   Second one on 18/10: was given without MTX 

 

- Will take vincristine 

 

Pain wise:

----------

No pain today.

On Gabapentin 300*2

 

Nephrology:

----------

Stable blood pressure readings:

On: amlodipine  2.5 mg q24h 

 

Cardiology:

-----------

SVT twice on 20/10

On: Inderal     10 mg *3  for SVT

 

Neurology:

----------

On: 

Keppra      300MG   BID 

Diamox      250MG PO Q12H 

 

PLAN :

=======

- Observe blood pressure readings 

- Check pending cultures 

- Follow up on LFT

- Port placement on sunday.

 

------------Nutrition/Diet Plan----------

 low bacterial

 

------------VTE prophylaxis Plan---------

Patient Age < 10 years:NA

 

 

=================================Discharge planning note========================

Reason of admission: combined relapse

 

Estimated length of stay:14 days

 

Goals of Care/needed interventions:

Chemotherapy

 

Special Needs upon Discharge

No Special needs

 

Delayed discharge

No




================================================================================
Date: 2024-10-25 06:03
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: AL SHEIKH,BUSHRA MAHMOUD IBRAHIM
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:11    BA                     ALL-relaps                         

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-24 20:11    BA                                            36.20 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:13    BA                     24/10                              

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     general                            

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     Throb                              

  2024-10-24 20:00    BA                     Sharp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     SUDDEN ONSET                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     analgesic                          

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     GABAPENTIN CAP,ORAL 300MG/tab      

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     GABAPENTIN CAP,ORAL 300MG PO       

                                             BID                                

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     0                                  

  2024-10-25 00:00    BA                     0                                  

  2024-10-25 04:00    BA                     0                                  

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     GABAPENTIN CAP,ORAL 300MG PO       

                                             BID                                

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     0=Alert                            

  2024-10-25 00:00    BA                     0=Alert                            

  2024-10-25 04:00    BA                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 20:00    BA                     NA                                 

  2024-10-25 00:00    BA                     NA                                 

  2024-10-25 04:00    BA                     NA                                 

 

 

 

 

 




================================================================================
Date: 2024-10-24 18:14
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: NAWRASI,HANEEN ANWAR ABDEL LATIF
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:29    HN                     suspected relapse B-ALL            

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     na                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-24 08:29    HN                                            36.20 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:32    HN                     23.10                              

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     general pain                       

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     Sharp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     disease process                    

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     analgesics                         

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     GABAPENTIN CAP,ORAL 300MG PO       

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     GABAPENTIN CAP,ORAL 300MG PO       

                                             BID                                

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     0                                  

     Comment: NRS

  2024-10-24 12:00    HN                     0                                  

  2024-10-24 16:00    HN                     0                                  

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     GABAPENTIN CAP,ORAL 300MG PO       

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     0=Alert                            

  2024-10-24 12:00    HN                     0=Alert                            

  2024-10-24 16:00    HN                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     NA                                 

  2024-10-24 12:00    HN                     NA                                 

  2024-10-24 16:00    HN                     NA                                 

 

 

 

 

 




================================================================================
Date: 2024-10-24 18:08
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: NAWRASI,HANEEN ANWAR ABDEL LATIF
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:29    HN                     suspected relapse B-ALL            

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     na                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-24 08:29    HN                                            36.20 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:32    HN                     23.10                              

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     general pain                       

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     Sharp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     disease process                    

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     analgesics                         

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     GABAPENTIN CAP,ORAL 300MG PO       

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     GABAPENTIN CAP,ORAL 300MG PO       

                                             BID                                

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     0                                  

     Comment: NRS

  2024-10-24 12:00    HN                     0                                  

  2024-10-24 16:00    HN                     0                                  

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     GABAPENTIN CAP,ORAL 300MG PO       

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     0=Alert                            

  2024-10-24 12:00    HN                     0=Alert                            

  2024-10-24 16:00    HN                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 08:00    HN                     NA                                 

  2024-10-24 12:00    HN                     NA                                 

  2024-10-24 16:00    HN                     NA                                 

 

 

 

 

 




================================================================================
Date: 2024-10-24 17:36
Type: CONSULT NOTE
Author: HASHEM,FARAH MOTAZ FEKRY
Location: KHCC-6H-PEDIATRIC
Service: SOCIAL WORK
================================================================================

'
Patient was seen at her bedside for a follow up, in response to consult. 

Accompanied by father and grandmother. She was conscious, oriented, responsive, 

but slightly cooperative and minimally engaged in guided discussion. She was 

reserved, sad, calm, low affect. Proper appetite, normal sleep. No pain, no 

fatigue. The patient repeatedly stated she wanted to go home and play with her 

siblings. She refused to engage in any activity despite numurous attempts. 

Nonetheless, she reported she no longer feels heat in her hands. She exhibited 

symptoms of sadness and worry because she misses her siblings and is still unabl

e 

to go home.

Provided active listening, emotional validation and support, reassurance, and

encouragement to patient. Provided family support to father and grandmother.

 

I asked Dr. ********** ********** **********h if it would be possible to bring the patient's **********-

year-old cousin to visit her at the center so the patient can feel better. 

However, due to the patient's medical condition, Dr. Amal said that would not be

 

possible. 

 

To be followed for further assessment and support as needed.

 




================================================================================
Date: 2024-10-24 13:58
Type: NUTRITION PROGRESS NOTE
Author: AL-NAJDAWI,ELHAM AHMAD MAHMOUD
Location: KHCC-6H-PEDIATRIC
Service: NUTRITION
================================================================================

'
--------------------------------------------------------------------------------

                             Nutrition Progress Note 

--------------------------------------------------------------------------------

Diagnosis:Relapse B-ALL 

 

Reason for nutrition follow up:admitted for post icu ,SVT ,hypertension

 

 

Weight change since last assessment:

10/23/24 @ 1637     WEIGHT: 79.81 lb. ( 36.28 kg.)

Recent lab findings/imaging:

 

 

 

  Collection time:          Oct 24, 2024@00:31:13

   Test Name                 Result    Units           Range

 

ALBUMIN                       3.9      g/dL        3.6 - 5.3

 

   Collection time:          Oct 24, 2024@00:31:13

   Test Name                 Result    Units           Range

 

CHOLESTEROL                252.00      mg/dL 

TRIGLYCERIDE               299.00 H    mg/dL      Ref: <=150

HDL CHOLESTEROL             43.90      mg/dL Ref: Children: See portal

LDL CHOLESTEROL,SERUM         148 H    mg/dl      Ref: <=100

 

Current nutritional supplements/medications: amLODIPine TAB ,    dexAMETHasone 

TAB 

 

Nutrition status :

.adequate oral intake 

.patient over weight 

.weight gain 2 kg last 1 month 

.hyperlipidemia 

.Abdominal U/S 22/10 : MILD HEPATOMEGALY 

.patient today npo 

 

Recommendations and nutrition plan of care:

patient father was educated about low fat diet , low bacterial diet 

when diet resume give patient  low fat, low salt  diet , low bacterial diet

rtc in nutrition clinic for weight management 




================================================================================
Date: 2024-10-24 11:27
Type: PHYSICIAN PEDIATRIC MINOR PROCEDURE NOTE
Author: MUHANNA,AYA MUHANNA ADEL
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
PATIENT NAME:**********      PATIENT SEX:FEMALE

PATIENT NATIONAL ID:**********

PATIENT DOB:**********            PATIENT AGE:8yr 9mo

ATTENDING PHYSICIAN - ABU GHOSH,AMAL MOUSA DEEB,DATE : Oct 17,2024

===============================================================================

                         Pediatric Minor Procedures Note

===============================================================================

Active problems - Computerized Problem List is the source for the following:

 

 1. Leukemia, Lymphocytic

 2. Syrian refugee

 3. sever vomiting after anesthesia 

 4. delayed MTX excretion

 5. Pancytopenia

 6. septic shock ICU admission 

 7. TBNK flow: low

 8. chemosensitivity for workup

 9. Suspected relapse

10. Papilledema 

Diagnosis: ALL 

Code:      FULL CODE 

Anesthetist: DR **********R 

Nurse: PICU NURSE 

 

Allergy:ALLERGIES/ADVERSE REACTIONS - NONE FOUND

-----------------------------------Procedure-----------------------------------

Procedure: TIT AND BONE MARROW 

Anesthesia

General

Under aseptic technique :Yes

---------------------Lumbar Puncture and Intrathecal Chemotherapy--------------

Lumbar Puncture was done

CSF samples sent for:

Analysis

Cytology

Intrathecal Chemotherapy was/were administered

MTX 12 mg

ARA-C 36 mg

Hydrocortisone 24 mg

Total volume given 12 ML

Total CSF withdrawn 3 ML

-------------------------Bone marrow aspirate and/ or biopsy-------------------

Bone marrow aspirate and/ or biopsy

Unilateral

Samples were sent for

Morphology

Flowcytometry

Cytogenetics

FISH

 

PROCEDURE WAS DONE WENT SMOOTH WITH NO COMPLICATIONS 

bone marrow aspirate and biopsy / right 

LUMBAR PUNCTURE FIRST TRIAL 

CSF SAMPLES WERE SENT FOR ANALYSIS AND CYTOLOGY 

RECEIVED INTRATHECAL CHEMOTHERAPY 

LUMBAR PUNCTURE SITE IS CLEAR 




================================================================================
Date: 2024-10-24 11:24
Type: CONSULT NOTE
Author: ALIWAT,MAHA IBRAHIM ATA
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/GASTROENTEROLOGY
================================================================================

'



================================================================================
Date: 2024-10-24 11:16
Type: PHYSICIAN PRE-DISCHARGE NOTE
Author: ALADWAN,MAI MAHMOUD SULTAN
Location: KHCC-6H-PEDIATRIC
Service: INTERNAL MEDICINE
================================================================================

'
Patient Name:**********  Patient ID:**********

Patient Age:8yr **********mo    Patient DOB:**********

Patient Sex:FEMALE 

--------------------------------------------------------------------------------

                           PRE-DISCHARGE NOTE

--------------------------------------------------------------------------------

Code Status:Full code

Admission Diagnosis: Combined relapsed B-ALL

 

Admission Date:Oct 16,2024

Active Problem: hypertension

--------------------------------------------------------------------------------

Significant finding from history and exam 

----------------Subjective---------------

ADD SIGNIFICANT FINDINGS

HNNET:No headache , No earache , No sore throat 

Cardiopulmonary:No cough , No runny nose , no chest pain

GI/Diet:No vomiting, No abdominal pain , no change in bowel habits

Neuromuscular:No pain , no deformity

Genitourinary:No Dysuria , No frequency , no change in urine color or smell

 

----------------Objective----------------

-General Condition: cooperative, pleasant, looks well and comfortable, not in 

 distress

-HNNET: No conjunctival pallor, No jaundice, No mouth ulcers, No lymphadenopathy

-Chest: No use of accessory muscles, GAEBL, No wheezes, No crackles 

-Cardiovascular: Normal S1, S2, No murmurs, No added sounds.

-Abdomen: Not distended, soft , no rigidity, no gaurding 

-Musculoskeletal: ambulatory with normal range of motion across joints 

-Skin: No skin lesions, no rash/ petichiae.

--------------------------------------------------------------------------------

Significant laboratory findings 

- CMV PCR POSITIVE : 789 

 

CSF ANALYSIS 

   Collection time:          Oct 24, 2024@11:24:56

   Test Name                 Result    Units           Range

GLUCOSE CSF                 57.60 L    mg/dl         60 - 80

PROTEIN CSF                138.00 H    mg/dL         15 - 45

CSF-RBC'S                       1      /uL             0 - 1

CSF-TOTAL NUCLEATED CELLS (TNC)      2 /uL             0 - 5

 

--------------------------------------------------------------------------------

Significant Radiology findings 

 

Brain CT scan with contrast 15/10 : 

No intracranial haemorrhage, midline shift or herniation. Petent dual venous 

sinuses 

 

Brain MRI 17/10 : Cranial nerve thickening with enhancement, along with 

involvement of the cavernous sinus structures, the pituitary stalk and the 

pharyngeal space. Finding are likely representing leukemic infiltration.

 

Renal Doppler U/S 17/10 : Hepatosplenomegaly with liver span 14 cm and spleen 

span 14.6 cm. Unremarkable normal renal Doppler scan, no signs of renal artery 

stenosis.

 

Abdominal U/S 22/10 : MILD HEPATOMEGALY 

--------------------------------------------------------------------------------

Procedures applied during hospitalization:

ITT 24/10

((())))

--------------------------------------------------------------------------------

Important development during hospitalization

- Zaher **********-********** is an ********** Year old girl a case of low risk B cell ALL

- Status post: off therapy on 12/12/2023

- Admitted as case of combined relapse B-ALL on 16/10.

- Transferred to ICU 17-23/10 for elevated blood pressure readings, transferred 

back to floor on 23/10.

 

ER

===

on 15/10:

---------

- she presented to ER with headache since 1 month that got 

worse today associated with photophobia and unsteady gait. She also has polyurea

 

but no vomiting ,no abdominal pain. 

Afebrile 

- she was found to be hypertensive.

Brain CT was done:No intracranial 

haemorrhage, midline shift or herniation, Petent dual venous sinuses.

- she was given hydralazine and nephrology consulted :no need to start 

antihypertensive medication to follow up in clinic 

- peripheral flow was sent showed: 8 % blast

 

on 16/10:

--------

- re-presented to ER with same complaint. 

 

on exam:

- there is sluggish left pupil , limitation in eye movement , multidirectional 

nystagmus , wide based gait , ataxic , can't do tandem gait 

 

 

Consults:

---------

- Opthalmology -> left eye exotropia + limitation on adduction , 

                  has papilledema- treat her increased ICP- 

                  do Brain + Orbit Mri to rule out brain versus orbital 

                  leukemic infiltrtaion is needed

                  diamox dose + steroid is recommended to decrease 

                  intracranial pressure utill the underlying cause resolve 

 

- Nephrology consulted -> start on amlodipine 2.5mg Qday 

Renal Doppler U/S 17/10 : Hepatosplenomegaly with liver span 14 cm and spleen 

span 14.6 cm. Unremarkable normal renal Doppler scan, no signs of renal artery 

stenosis.

 

Medications:

------------

-recieved perflgan , Hydralazine and dexamethasone 4 mg

 => her headache improved 

 

 

Labs:

-----

- CBC: hemoglobin 13.3 , WBC 6.6 , platlets 97 , ANC 2400

- Chesmitry : normal

 

so she was admitted to floor on keppra 300 mg*2, diamox 250mg*2 , amlodipine 

2.5mg Qday

 

Brain and orbit MRI done after admission : FREE AS PRIMARY READING

 

Floor

=====

17/10 :

Nephrology wise:

-----------------

-last night she recived 2 hydralazine for high blood pressure reading

-persinstantly hypertensive regardless hydralazine ( 140s/100s)

-renal ultrasound:

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

so transferred to PICU to manage high blood pressure reading on 17/10.

 

ICU 17-23/10

=============

oncology: 

---------

17/10 :

- started on dexamethasone PO 8mg/m2

- has combined relapse:

Bone marrow biopsy showed : 70% blasts 

triple IT given , LP done : CNS +

- chemotherapy and 2nd triple IT held due to transaminitis

- Has left eye exotropia + limitation on adduction , bilateral papilledma 

 

MRI 16/10: optic nerve swelling. 

 

 

Respiratory :

--------------

- ON room air  , normal oxygen saturation

- Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

Cardiovascular :

-----------------

- 17/10 : echo : mild mitral valve prolapse with no MR (benign )

 

- 20/10 : developed SVT twice and received one dose of adenosine 

          and Dr. ********** **********h added Inderal 10 mg BID , did not re-occur.

 

- Heart rate 100-220

 

- Normal capillary refill

- LINE : periphral 

 

 

Nephrology :

--------------

Blood pressure 100-120/60-70 (95th centile)= 116/77

 

Controlled on :

- Hydralazine 0.2mg/kg/dose q4h prn 

- amlodipine 2.5 mg q24h 

- Inderal 10 mg *3  for SVT

 

Last :

- urine output : 2.5 ml/kg/hr

- balance:-140 ml

 

Renal doppler U/S 17/10 :

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

 

Central nervous system :

------------------------

- CONSCIOUS , ALERT ORIENTED 

- GCS : 15/15 

- left eye exotropia (improved)

 

ON :

paracetamol oral PRN 

gabapentin  300MG ORAL BID 

Keppra      300MG   BID 

Diamox      250MG PO Q12H 

 

- brain ct scan with contrast 15/10 : unremarkable 

- brain MRI 17/10 : optic nerve swelling 

 

 

Gastrointestinal :

-------------------

- She has rising transaminases (ALT>AST) with normal bilirubin and normal 

coagulation profile, glucose, and albumin

 

Trend : 17/10 (167/152) -> 21/10 (711/432) -> 22/10 (954/234)

        -> 23/10 (895/234) Today

 

- Clinically she has hepatomegaly without tenderness. No jaundice. 

 

- Liver U/S 22.Oct.2024: hepatosplenomegaly with no focal lesion 

 

- CMV PCR : 784

 

- Exam : SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

On :

- low bacterial diet 

- nexium 

- IV fluid maintenance 

 

ABDOMINAL U/S 22/10 : MILD HEPATOMEGALY 

 

 

Infectious disease:

--------------------

for persisntent tacycardia , septic workup and was started on tazocin and 

amikacin then after 3 days upgraded into meropenem and vancomycin then after 2 

days downgraded into cefepime for 3 days

 

- remained afebrile , currently off antibiotics

 

ON: 

Prophylaxis : Bactrim 

 

Cultures:

-blood culture 19/10: pending 

-blood culture 17/10 : free

-stool culture 17/10 : Negative for Salmonella and Shigella 

 

- CMV PCR POSITIVE : 789 

 

Floor:

======

Patient was treansferred back to the floor on 24/10 after stabilizing blood 

pressure readings.

 

Infectious:

----------

Afebrile off antibiotics.

On prophylactic bactrim.

 

Gastrointestinal:

-----------------

LFTS today: 625/89 (trending down).

Yesterday: 859/234

 

Hematology-oncology:

--------------------

Last CBC

Hemoglobin: 

WBC: 

Platelets: 

ANC:

 

On dexamethasome 4*2.

Today she is due ITT (without MTX).

CSF ANALYSIS 

   Collection time:          Oct 24, 2024@11:24:56

   Test Name                 Result    Units           Range

GLUCOSE CSF                 57.60 L    mg/dl         60 - 80

PROTEIN CSF                138.00 H    mg/dL         15 - 45

CSF-RBC'S                       1      /uL             0 - 1

CSF-TOTAL NUCLEATED CELLS (TNC)      2 /uL             0 - 5

 

 

Chemotherapy plan?????

port???????

 

 

Pain wise:

----------

No pain today.

On Gabapentin 300*2

 

Nephrology:

----------

Stable blood pressure readings:

    B/P: 110/70*

    B/P: 107/72*

    B/P: 120/74*

    B/P: 122/70*

On:amlodipine  2.5 mg q24h 

 

Cardiology:

-----------

SVT on 20/10, no recurrence.

on:

Inderal     10 mg *3  for SVT

 

 

Neurology:

----------

On: 

Keppra      300MG   BID 

Diamox      250MG PO Q12H 

 

 

PLAN:

=====

- observe blood pressure readings 

- follow up on LFT

- Port placement on sunday.

 

 

-------------------------------------------------------------------------------

Discharge Diagnosis: Combined relapse B-ALL

Discharge Date:Oct 24,2024

Discharge type: Elective Discharge

-------------------------------------------------------------------------------

Discharge medications:

(((((())))))

-------------------------------------------------------------------------------

Pending Test Results:

(((((()))))))))

-------------------------------------------------------------------------------

--------------------------Patient condition upon discharge --------------------

Glasgow Coma scale:15/15

 

Performance status: 0 Full Active 

Pain Scale: 0

 

-------------------------------------------------------------------------------

---------------------------Follow up plan instructions ------------------------

List of follow-up appointments and referrals:

>> RETURN TO CLINIC LEUK-PED-RAWAD RIHANI Oct 27, 2024 **********rn********** **********

 

Advice on Discharge: Diet:regular

 

When to obtain urgent care:

Shortness of Breath 

Altered level of consciousness 

Uncontrolled pain 

Fever Higher than 38.0 C

Uncontrolled chemo radiotherapy side effect(for example nausea vomiting and 

diarrhea) 

post operative complication (for example discharge from site of surgery)

 

How to obtain urgent care:

During Working Hours (8Am -4Pm) Sunday to Thursday 

Call center number (+**********5300460)

You can always call your primary care coordinator for any help

After Working Hours emergency Room (adults and pediatrics)




================================================================================
Date: 2024-10-24 11:09
Type: PHYSICIAN PEDIATRIC MINOR PROCEDURE NOTE
Author: MUHANNA,AYA MUHANNA ADEL
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
PATIENT NAME:**********      PATIENT SEX:FEMALE

PATIENT NATIONAL ID:**********

PATIENT DOB:**********            PATIENT AGE:8yr 9mo

ATTENDING PHYSICIAN - ABU GHOSH,AMAL MOUSA DEEB,DATE :Oct 24,2024

===============================================================================

                         Pediatric Minor Procedures Note

===============================================================================

Active problems - Computerized Problem List is the source for the following:

 

 1. Leukemia, Lymphocytic

 2. Syrian refugee

 3. sever vomiting after anesthesia 

 4. delayed MTX excretion

 5. Pancytopenia

 6. septic shock ICU admission 

 7. TBNK flow: low

 8. chemosensitivity for workup

 9. Suspected relapse

10. Papilledema 

 

Diagnosis: ALL 

Code:      FULL CODE 

Anesthetist: ********** AL BAIK

Nurse:     ********** **********NE********** 

 

Allergy:ALLERGIES/ADVERSE REACTIONS - NONE FOUND

 

-----------------------------------Procedure-----------------------------------

Procedure: TIT 

Anesthesia

General

Under aseptic technique :Yes

 

CYTARABINE 36 MG

HYDROCORTISONE 24 NG

IN VOLUME 6 ML 

OUT 3 ML

 

---------------------Lumbar Puncture and Intrathecal Chemotherapy--------------

Lumbar Puncture was done

CSF samples sent for:

Analysis

Cytology

 

PROCEDURE WAS DONE WENT SMOOTH WITH NO COMPLICATIONS 

LUMBAR PUNCTURE FIRST TRIAL 

CSF SAMPLES WERE SENT FOR ANALYSIS AND CYTOLOGY 

RECEIVED INTRATHECAL CHEMOTHERAPY 

LUMBAR PUNCTURE SITE IS CLEAR 




================================================================================
Date: 2024-10-24 10:52
Type: PEDIATRIC PHYSICIAN PROGRESS NOTE
Author: ALADWAN,MAI MAHMOUD SULTAN
Location: KHCC-6H-PEDIATRIC
Service: INTERNAL MEDICINE
================================================================================

'
--------------------------------------------------------------------------------

                         Progress note

--------------------------------------------------------------------------------

- Zaher **********-**********ham is an ********** Year old girl a case of low risk B cell ALL

- status post: off therapy on 12/12/2023

- Admitted as case of combined relapse B-ALL on 16/10

- Transferred to ICU 17-23/10 for elevated blood pressure readings, transferred 

back to floor on 23/10.

 

----------------Subjective---------------

HNNET:No headache , No earache , No sore throat 

Cardiopulmonary:No cough , No runny nose , no chest pain

GI/Diet:No vomiting, No abdominal pain , no change in bowel habits

Neuromuscular:No pain , no deformity

Genitourinary:No Dysuria , No frequency , no change in urine color or smell

 

----------------Objective----------------

-General Condition: cooperative, pleasant, looks well and comfortable, not in 

 distress

-HNNET: No conjunctival pallor, No jaundice, No mouth ulcers, No lymphadenopathy

-Chest: No use of accessory muscles, GAEBL, No wheezes, No crackles 

-Cardiovascular: Normal S1, S2, No murmurs, No added sounds.

-Abdomen: Not distended, soft , no rigidity, no gaurding 

-Musculoskeletal: ambulatory with normal range of motion across joints 

-Skin: No skin lesions, no rash/ petichiae.

 

 

----------------Last Vital signs---------

10/24/24

09:00

    T:   98.1 F (36.7 C)

    P:   105

    R:   22

    B/P: 107/72*

    Pulse Oximetry: 99%

03:55

    T:   98.1 F (36.7 C)

    P:   104

    R:   22

    B/P: 120/74*

    Pulse Oximetry: 99%

00:04

    T:   98.2 F (36.8 C)

    P:   123

    R:   24

    B/P: 122/70*

    Pulse Oximetry: 99%

 

----------------Intake/output------------

n/a

 

---------------Most recent lab-----------

GLUCOSE: 94.60 

CREATININE: 0.4 

SODIUM: 139.80 

POTASSIUM: 4.32 

CHLORIDE: 110.70 

CALCIUM: 9.18 

PO4: 4.56 

URIC ACID: 3.71 

ALBUMIN: 3.9 

BILIRUBIN,TOTAL: 0.32 

ALKALINE PHOSPHATASE: 151.000 

SGOT: 89.30  H

MAGNESIUM: 2.45 

BICARBONATE: 13.3  L

ALANINE AMINO TRANSFERASE: 625.0  H

BILIRUBIN DIRECT,SERUM LEVEL: 0.12 

PROTEIN(SERUM): 7.0 

UREA SERUM LEVEL: 48.60  H

ADJUSTED CALCIUM: 9.24 

 

CHOLESTEROL: 252.00 

TRIGLYCERIDE: 299.00  H

HDL: 43.90 

LDL CHOLESTEROL: 148  H

 

 

 

WBC: 8.30 

RBC: 4.49 

MCV: 83.8 

MCH: 28.9 

MCHC: 34.6 

RDW: 15.4  H

PLT: 89  L

MPV: 7.5 

LYMPHS: 66.4  H

MONOCYTES: 3.9 

EOSINO: 0.2  L

BASO: 0.2 

HB (HGB): 13.0 

NEUTROPHIL: 29.3  L

PCV: 37.6 

NEUTROPHILS#: 2.4 

LYMPHOCYTES#: 5.5 

MONOCYTES#: 0.3  L

EOSINOPHILS#: 0.0 

BASOPHILS#: 0.0 

 

CSF ANALYSIS 

   Collection time:          Oct 24, 2024@11:24:56

   Test Name                 Result    Units           Range

GLUCOSE CSF                 57.60 L    mg/dl         60 - 80

PROTEIN CSF                138.00 H    mg/dL         15 - 45

CSF-RBC'S                       1      /uL             0 - 1

CSF-TOTAL NUCLEATED CELLS (TNC)      2 /uL             0 - 5

 

 

Cultures: 

-blood culture 19/10: pending 

-blood culture 17/10 :Aerobic culture:No growth after five days of incubation. 

   Anaerobic culture:No growth after five days of incubation 

-stool culture 17/10 :Negative for Salmonella and Shigella 

 

----Radiology during current admission---

Brain CT scan with contrast 15/10 : 

No intracranial haemorrhage, midline shift or herniation. Patent dual venous 

sinuses 

 

Brain MRI 17/10 : Cranial nerve thickening with enhancement, along with 

involvement of the cavernous sinus structures, the pituitary stalk and the 

pharyngeal space. Finding are likely representing leukemic infiltration.

 

Renal Doppler U/S 17/10 : Hepatosplenomegaly with liver span 14 cm and spleen 

span 14.6 cm. Unremarkable normal renal Doppler scan, no signs of renal artery 

stenosis.

 

Abdominal U/S 22/10 : MILD HEPATOMEGALY 

------------------Consults---------------

- Opthalmology -> left eye exotropia + limitation on adduction , 

                  has papilledema- treat her increased ICP- 

                  do Brain + Orbit Mri to rule out brain versus orbital 

                  leukemic infiltrtaion is needed

                  diamox dose + steroid is recommended to decrease 

                  intracranial pressure utill the underlying cause resolve 

 

- Nephrology consulted -> start on amlodipine 2.5mg Qday 

                          Renal U/S tomorrow 

-----------------Medications-------------

paracetamol oral PRN 

gabapentin  300MG ORAL BID 

 

Keppra      300MG   BID 

Diamox      250MG PO Q12H 

 

amlodipine  2.5 mg q24h 

Inderal     10 mg *3  for SVT

 

Bactrim prophylaxis

 

Histal

 

Dexamethasone 4 mg BID

Lansoprazole

Oral anal

----------------Active Problems----------

Active problems - Computerized Problem List is the source for the following:

 

 1. Leukemia, Lymphocytic  Acute, B-cell  Low Risk   EOI : negative MRD

 2. Syrian refugee  lives in refugee camp 

 3. sever vomiting after anesthesia 

 4. delayed MTX excretion

 5. Pancytopenia  Recurrent Anemia

 6. septic shock ICU admission 

 7. TBNK flow: low

 8. chemosensitivity for workup

 9. Suspected relapse

10. Papilledema 

 

----------Assesment and Plan of care-----

- Z**********er Al-********** is an ********** Year old girl a case of low risk B cell ALL

- status post: off therapy on 12/12/2023

- Admitted as case of combined relapse B-ALL on 16/10

- Transferred to ICU 17-23/10 for elevated blood pressure readings, transferred 

back to floor on 23/10.

 

ER

===

on 15/10:

---------

- she presented to ER with headache since 1 month that got 

worse today associated with photophobia and unsteady gait. She also has polyurea

 

but no vomiting ,no abdominal pain. 

Afebrile 

- she was found to be hypertensive.

Brain CT was done:No intracranial 

haemorrhage, midline shift or herniation, Petent dual venous sinuses.

- she was given hydralazine and nephrology consulted :no need to start 

antihypertensive medication to follow up in clinic 

- peripheral flow was sent showed: 8 % blast

 

on 16/10:

--------

- re-presented to ER with same complaint. 

 

on exam:

- there is sluggish left pupil , limitation in eye movement , multidirectional 

nystagmus , wide based gait , ataxic , can't do tandem gait 

 

 

Consults:

---------

- Opthalmology -> left eye exotropia + limitation on adduction , 

                  has papilledema- treat her increased ICP- 

                  do Brain + Orbit Mri to rule out brain versus orbital 

                  leukemic infiltrtaion is needed

                  diamox dose + steroid is recommended to decrease 

                  intracranial pressure utill the underlying cause resolve 

 

- Nephrology consulted -> start on amlodipine 2.5mg Qday 

Renal Doppler U/S 17/10 : Hepatosplenomegaly with liver span 14 cm and spleen 

span 14.6 cm. Unremarkable normal renal Doppler scan, no signs of renal artery 

stenosis.

 

Medications:

------------

-recieved perflgan , Hydralazine and dexamethasone 4 mg

 => her headache improved 

 

 

Labs:

-----

- CBC: hemoglobin 13.3 , WBC 6.6 , platlets 97 , ANC 2400

- Chesmitry : normal

 

so she was admitted to floor on keppra 300 mg*2, diamox 250mg*2 , amlodipine 

2.5mg Qday

 

Brain and orbit MRI done after admission : FREE AS PRIMARY READING

 

Floor

=====

17/10 :

Nephrology wise:

-----------------

-last night she recived 2 hydralazine for high blood pressure reading

-persinstantly hypertensive regardless hydralazine ( 140s/100s)

-renal ultrasound:

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

so transferred to PICU to manage high blood pressure reading on 17/10.

 

ICU 17-23/10

=============

oncology: 

---------

17/10 :

- started on dexamethasone PO 8mg/m2

- has combined relapse:

Bone marrow biopsy showed : 70% blasts 

triple IT given , LP done : CNS +

- chemotherapy and 2nd triple IT held due to transaminitis

- Has left eye exotropia + limitation on adduction , bilateral papilledma 

 

MRI 16/10: optic nerve swelling. 

 

 

Respiratory :

--------------

- ON room air  , normal oxygen saturation

- Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

Cardiovascular :

-----------------

- 17/10 : echo : mild mitral valve prolapse with no MR (benign )

 

- 20/10 : developed SVT twice and received one dose of adenosine 

          and Dr. ********** **********h added Inderal 10 mg BID , did not re-occur.

 

- Heart rate 100-220

 

- Normal capillary refill

- LINE : periphral 

 

 

Nephrology :

--------------

Blood pressure 100-120/60-70 (95th centile)= 116/77

 

Controlled on :

- Hydralazine 0.2mg/kg/dose q4h prn 

- amlodipine 2.5 mg q24h 

- Inderal 10 mg *3  for SVT

 

Last :

- urine output : 2.5 ml/kg/hr

- balance:-140 ml

 

Renal doppler U/S 17/10 :

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

 

Central nervous system :

------------------------

- CONSCIOUS , ALERT ORIENTED 

- GCS : 15/15 

- left eye exotropia (improved)

 

ON :

paracetamol oral PRN 

gabapentin  300MG ORAL BID 

Keppra      300MG   BID 

Diamox      250MG PO Q12H 

 

- brain ct scan with contrast 15/10 : unremarkable 

- brain MRI 17/10 : optic nerve swelling 

 

 

Gastrointestinal :

-------------------

- She has rising transaminases (ALT>AST) with normal bilirubin and normal 

coagulation profile, glucose, and albumin

 

Trend : 17/10 (167/152) -> 21/10 (711/432) -> 22/10 (954/234)

        -> 23/10 (895/234) Today

 

- Clinically she has hepatomegaly without tenderness. No jaundice. 

 

- Liver U/S 22.Oct.2024: hepatosplenomegaly with no focal lesion 

 

- CMV PCR : 784

 

- Exam : SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

On :

- low bacterial diet 

- nexium 

- IV fluid maintenance 

 

ABDOMINAL U/S 22/10 : MILD HEPATOMEGALY 

 

 

Infectious disease:

--------------------

for persisntent tacycardia , septic workup and was started on tazocin and 

amikacin then after 3 days upgraded into meropenem and vancomycin then after 2 

days downgraded into cefepime for 3 days

 

- remained afebrile, currently off antibiotics

 

ON: 

Prophylaxis : Bactrium 

 

Cultures:

-blood culture 19/10: pending 

-blood culture 17/10 : free

-stool culture 17/10 : Negative for Salmonella and Shigella 

 

- CMV PCR POSITIVE : 789 

 

Floor:

------

Patient was treansferred back to the floor on 24/10 after stabilizing blood 

pressure readings.

 

Infectious:

----------

Afebrile off antibiotics.

On prophylactic bactrim.

 

Gastrointestinal:

-----------------

LFTS today: 625/89 (trending down).

Yesterday: 859/234

 

Lipid profile: 

CHOLESTEROL: 252.00 

TRIGLYCERIDE: 299.00  H

HDL: 43.90 

LDL CHOLESTEROL: 148  H

 

Hematology-oncology:

--------------------

Hemoglobin: 13

WBC: 8.3

Platelets: 89 

ANC:2400

 

On dexamethasome 4*2

Today she is due ITT  (without MTX).

CSF ANALYSIS 

   Collection time:          Oct 24, 2024@11:24:56

   Test Name                 Result    Units           Range

GLUCOSE CSF                 57.60 L    mg/dl         60 - 80

PROTEIN CSF                138.00 H    mg/dL         15 - 45

CSF-RBC'S                       1      /uL             0 - 1

CSF-TOTAL NUCLEATED CELLS (TNC)      2 /uL             0 - 5

 

Pain wise:

----------

No pain today.

On Gabapentin 300*2

 

Nephrology:

----------

Stable blood pressure readings:

    B/P: 110/70*

    B/P: 107/72*

    B/P: 120/74*

    B/P: 122/70*

On:amlodipine  2.5 mg q24h 

 

 

Cardiology:

-----------

SVT on 20/10 only.

 

on:

Inderal     10 mg *3  for SVT

 

Neurology:

----------

On: 

Keppra      300MG   BID 

Diamox      250MG PO Q12H 

 

PLAN :

=======

- observe blood pressure readings 

- check pending cultures 

- labs tomorrow

- follow up on LFT

- follow up regarding chemotherapy complications

- Port placement on sunday.

 

------------Nutrition/Diet Plan----------

 low bacterial

 

------------VTE prophylaxis Plan---------

Patient Age < 10 years:NA

 

 

=================================Discharge planning note========================

Reason of admission: combined relapse

 

Estimated length of stay:14 days

 

Goals of Care/needed interventions:

IV antibiotics, Pain Management , Chemotherapy, Consult, Radiology

 

Special Needs upon Discharge

No Special needs

 

Delayed discharge

Yes,Reason delayed chemo




================================================================================
Date: 2024-10-24 10:38
Type: NUTRITION BODY COMPOSITION ANALYSIS NOTE
Author: AL-NAJDAWI,ELHAM AHMAD MAHMOUD
Location: KHCC-6H-PEDIATRIC
Service: NUTRITION
================================================================================

'
--------------------------------------------------------------------------------

                        Body composition analysis form

--------------------------------------------------------------------------------

Body composition history         value   Normal range 

Weight (KG)                      35.3 

BMI                              20.3 

BMI /age percentiles             93%              over weight 

Body fat mass (kg)               13.9        4-8.1       over 

Body fat percentage %            39.4 

Skeletal muscle mass (kg)        10.4        10.4-12.6     normal 

Extracellular water ratio        0.388        0.36-0.39     normal 

Upper arm circumference(cm)      19.7 

Waist circumference(cm)          66.1 

Waist to hip ratio               0.81        0.75-0.85   normal 

 

 

 

  Body fat mass (kg) : over , need to loss 7 kg as fat from weight 

 

  Skeletal muscle mass (kg) : normal , maintian it 




================================================================================
Date: 2024-10-24 07:51
Type: CLINICAL PHARMACIST NOTE
Author: ZATRA,RAZAN TAWFIQ AREF
Location: KHCC-6H-PEDIATRIC
Service: PHARMACY
================================================================================

'
Patient Name: **********

Patient ID: **********-00-48145

Patient Age: 8yr **********mo

Height: 51.969 in [132.0 cm] (10/23/2024 16:37)

Weight: 79.81 lb [36.3 kg] (10/23/2024 16:37)

 

Allergies: Patient has answered NKA

 

Active Inpatient Medications (including Supplies):

 

     Active Inpatient Medications                           Status

=========================================================================

1)   DEXTROSE 5%/SODIUM CHLORIDE 0.9% INJ,SOLN in DEXTROSE  ACTIVE

       5%/NACL 0.9% [D] 500 ML  75 ml/hr IV

2)   GABAPENTIN CAP,ORAL  300MG PO BID                      ACTIVE

3)   LANSOPRAZOLE CAP,EC  15MG PO QDAY                      ACTIVE

4)   LORATADINE TAB,ORAL  10MG PO QDAY                      ACTIVE

5)   NYSTATIN SUSP,ORAL  100000UNIT/1ML PO TID SWISH AND    ACTIVE

       SWALLOW

6)   PARACETAMOL TAB  500MG PO Q6H PRN 15MG/KG/DOSE , PRN   ACTIVE

       FEVER >38.3

7)   PROPRANOLOL TAB  10MG PO TID 0.3 MG /KG/DOSE FOR SVT   ACTIVE

       TREATMENT

8)   SODIUM BICARBONATE MOUTHWASH  5 ML PO TID SWISH AND    ACTIVE

       SPLIT

9)   SULFAMETHOXAZOLE/TRIMETHOPRIM TAB  1 TABLET OF         ACTIVE

       TRIMETHOPRIM/SULFAMETHOXAZOLE 80MG TAB PO

       FR-SA@08-20 2.5 MG/KG/DOSE BID ON FRIDAY AND

       SATURDAY AS PCP PROPHYLAXIS .

10)  ZINC OXIDE PASTE  A SAMLL AMOUNT TOP TID ON PERIANAL   ACTIVE

       AREA

11)  acetaZOLAMIDE TAB  250MG PO BID 15mg/kg                ACTIVE

12)  amLODIPine TAB  2.5 MG PO QDAY as per nephro plan      ACTIVE

13)  dexAMETHasone TAB  4MG PO BID 8 MG /M2 QDAY DIVIDED    ACTIVE

       AS CHEMOTHERAPY .

14)  levETIRAcetam SOLN  300MG PO BID ppx 20mg/kg/day       ACTIVE

 

 

Zahr **********-sham is an ********** years old female patient, case of B cell "low risk"

off therapy since Dec 12,2023. 

 

Presented to ER with headache since 1 month ago associated with photophobia and 

unsteady gait. Admitted for further evaluation and management. 

 

Blood film was sent showed :8% blast

Bone marrow aspirate and biopsy : showed relapse 80% B-CELL ALL 

CNS relapse  ( CSF flow cytometry was consistent with relapse)

 

>> Started on dexamethasone  8mg/m2 on Oct 17,2024

>> First Triple intrathecal therapy on Oct 17,2024

 

- She had elevation in liver enzymes after TIT ALT/AST >> 900/400

 

MDC decision :in regards to her progressive transaminases, intrathecal will be 

given without methotrexate (only hydrocortisone and ARAC).

 

>> Given second intrathecal therapy today Oct 24,2024 as hydrocortisone and 

   cytarabine. 

 

She was transferred to PICU for high blood pressure readings, transferred back 

to floor after stabilization. 

 

Active issues:

-------------

1. Left eye exotropia, has papilledema

   Secondary to her increased intracranial pressure. 

   On acetazolamide. 

 

2. Hypertension:

   Currently controlled on:

   Amlodipine 2.5 mg q24h 

   Propranolol 10 mg TID for Supraventricular tachycardia (SVT).

 

3. Elevation in liver enzymes after TIT ALT/AST >> 900/400

   Improving, currently ALT/AST >> 625/29

   Impression: intrathecal induced versus disease ??

   For follow up. 

 

4.  bilateral wrist pain/neuropathy: on gabapentin 300mg BID. 

 

* on levETIRAcetam as prophylaxis. 

* On trimethoprim/sulfamethazole as Pneumocystis pneumonia (PCP) prophylaxis. 

 

Medications were reviewed and assessed.

 

Recommendations:

- Discontinue loratidine. 




================================================================================
Date: 2024-10-24 05:32
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: NASER,HALA HANI ALI
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:43    HN                     ALL relapse                        

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:53    HN                     na                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-23 19:43    HN                                            36.20 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:46    HN                     23/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:53    HN                     general                            

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:53    HN                     .FBS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:53    HN                     Sharp                              

  2024-10-23 19:53    HN                     Stab                               

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:53    HN                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:53    HN                     movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:53    HN                     medication                         

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:53    HN                     300 mg                             

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:53    HN                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:53    HN                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:53    HN                     GABAPENTIN CAP,ORAL                

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-24 00:00    HN                     0                                  

  2024-10-24 04:59    HN                     0                                  

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 19:54    HN                     300 mg GABAPENTIN CAP,ORAL         

  2024-10-24 05:31    HN                     GABAPENTIN CAP,ORAL                

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 20:00    HN                     0=Alert                            

  2024-10-24 00:00    HN                     0=Alert                            

  2024-10-24 04:00    HN                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 20:00    HN                     NA                                 

  2024-10-24 00:00    HN                     NA                                 

  2024-10-24 04:00    HN                     NA                                 

 

 

 

 

 

 




================================================================================
Date: 2024-10-23 18:04
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: ALMAJALI,RAHAF RAAD ZAID
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:48    RA                     ALL-relapes                        

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-23 17:48    RA                                            36.20 (kg)  

  2024-10-23 16:37    HZ                                            79.81 (lb)  

     Comment: Data retrieved from VistA Vitals Package

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:52    RA                     22/10                              

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:55    RA                     genral pain                        

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:55    RA                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:55    RA                     Sharp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:55    RA                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:55    RA                     movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:55    RA                     medication                         

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:55    RA                     GABAPENTIN CAP,ORAL                

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:55    RA                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:55    RA                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 17:55    RA                     GABAPENTIN CAP,ORAL                

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 16:03    RA                     0                                  

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 18:03    RA                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-23 18:03    RA                     NA                                 

 

 

 




================================================================================
Date: 2024-10-23 16:19
Type: LEUKEMIA MDC NOTE
Author: KANAAN,DANA SAEED AHMAD
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
 

MDC Leukemia note :23/10/2024

 

MDC DATE :23/10 /2024 

 

Diagnosis : 

Relapse B-ALL  combined CNS and  BM Relapse 

 

CYTOGENITICS / MOLECULAR STUDIES :

Pending 

 

case summary : 

- ********** year old female patient , case of B cell ALL

- status post: off therapy on 12/12/2023

on 15/10:

- she presented to ER with headache since 1 month that got 

worse today associated with photophobia and unsteady gait. She also has polyurea

 

but no vomiting ,no abdominal pain. She is Afebrile 

- she was found to be hypertense , Brain CT was done:No intracranial 

haemorrhage, midline shift or herniation, Petent dual venous sinuses.

- she was given hydralazine and nephrology consulted :no need to start 

antihypertensive medication to follow up in clinic 

- Blood film was sent showed :8 % blast

-BM asprate and biopsy : showed relapse 80% B-CELL ALL 

- bone marrow relapse  ( periphral flowcytometry  8% disease )

 

- CNS relapse  ( CSF flowcytometry was consistentt with relapse 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation .

MRI : optic nerve swelling 

 

during ICU admission :

 

She has rising transaminases (ALT>AST) with normal bilirubin and normal 

coagulation profile, glucose, and albumin

 

Clinically she has hepatomegaly without tenderness. No jaundice. 

 

Liver U/S 22.Oct.2024: hepatosplenomegaly with no focal lesion 

Viral workup: sent

 

hematology / ocology :

- started on dexamethasone  8mg/m2 17/10

-First Triple IT 17.Oct.2024

 

MDC decision :

in regards to her progressive transaminitis , IT  will be given tommorrow 

withouth methotrexate (only hydrocortisone amd ARAC ) .




================================================================================
Date: 2024-10-23 14:52
Type: INTERDISCIPLINARY FAMILY/PATIENT EDUCATION NOTE
Author: ALMAJALI,RAHAF RAAD ZAID
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
patient name:**********  patient ID:**********

patient age:**********yr **********mo    patient DOP:**********

patient sex:FEMALE    patient location:WARD LOC - **********C-5H-PEDIATRIC ICU

--------------------------------------------------------------------------------

                 INTERDISCIPLINARY PATIENT/FAMILY EDUCATION

--------------------------------------------------------------------------------

Wellingness to Learn : Yes

 

LEARNING BARRIERS (please mark the learning Barrier available)

K None 

 

Identify patient learning needs (mark the need)

Others 

*Information taught*

--------------------------------------------------------------------------------

1. Patients rights and responsibilities 

Date:Oct 23,2024,Who was taught:Mother 

Tools:Oral**********,Barriers:

atient rights and responsibilities are essential components of healthcare that 

help 

ensure respectful and effective interactions between patients and healthcare 

providers. 

Here?s a brief overview:

 

 

 

Patient Rights

 

1- Right to Information: Patients have the right to receive accurate and clear 

information bout their diagnosis, treatment options, and prognosis.

 

2- Right to Privacy: Patients have the right to confidentiality regarding their 

medical records and personal information.

 

3- Right to Consent: Patients must give informed consent before any treatment or

 

procedure is performed.

 

4- Right to Respect: Patients should be treated with dignity and respect by 

healthcare providers.

 

5- Right to Access Care: Patients have the right to access necessary healthcare 

services in a timely manner.

 

6- Right to Participate: Patients have the right to participate in decisions 

about their healthcare.

 

Patient understanding Evaluation/Comments:

Verbalizes basic concepts without assistance

--------------------------------------------------------------------------------

5. Daily activites, safe and effective use of equipment, exercise and/or 

rehabilitation technique

Date:Oct 23,2024,Who was taught:Mother 

Tools:**********K,Barriers:

Preventing falls, especially in vulnerable populations like the elderly or 

individuals 

with certain health conditions, is crucial for maintaining safety and health. 

Here are some effective strategies to reduce the risk of falling:

 

 

 

Remove Hazards: Keep floors clear of clutter, cords, and loose rugs. Ensure 

pathways are 

well-lit.

 

Patient understanding Evaluation/Comments:

Verbalizes basic concepts without assistance

--------------------------------------------------------------------------------

7. Pain management 

Date:Oct 23,2024,Who was taught:Mother 

Tools:OralK,Barriers:

Pain management is a critical aspect of healthcare that focuses on reducing and 

controlling pain to improve quality of life. Here?s an overview of various 

approaches 

and strategies used in pain management:

 

 

 

1. Medications

 

2. Physical Therapy

 

3. Interventional Techniques

 

4. Complementary Therapies

 

5. Psychological Support

 

6. Lifestyle Modifications

 

Diet and Nutrition: A balanced diet can contribute

 

Patient understanding Evaluation/Comments:

Verbalizes basic concepts without assistance




================================================================================
Date: 2024-10-23 14:29
Type: NUTRITION PROGRESS NOTE
Author: KHALAF,ZAIN MOHAMMAD MUSTAFA
Location: KHCC-6H-PEDIATRIC
Service: NUTRITION
================================================================================

'
--------------------------------------------------------------------------------

                             Nutrition Progress Note 

--------------------------------------------------------------------------------

Diagnosis:  B cell ALL

--------------------------------------------------------------------------------

Reason of Admission: 

admitted to pediatric intensive care unit due to observation for (hypertension)

--------------------------------------------------------------------------------

Current treatment modality:

 - status post: off therapy on 12/12/2023

--------------------------------------------------------------------------------

Oral Intake:Adequate (more than 60% of the total caloric requirements)

--------------------------------------------------------------------------------

Current Weight:34.5Kg        Height:134cm      BMI: 19.2

BMI/Age:********** 

The Patient is:Over Weight

 

Previous documented weight

10/16/24 @ 1810     WEIGHT: 76.06 lb. ( 34.57 kg.)

 

Ideal Body weight:29Kg

Weight /ideal body weight:119%

Weight /age:84%              height/age: 65% 

Total daily caloric requirement: 1800 kcal/d.

Total daily Protein requirement: 72   g/d.

-----------------------------Investigation--------------------------------------

Lipid profile:LIPID PROFILE Coll. datCHOL    TRIG    HDL     LDL

1/16/24 10:47                        123.00  70.60   47.70   61 

 

  Collection time:          Oct 17, 2024@00:07:29

   Test Name                 Result    Units           Range

ALBUMIN                       4.4      g/dL        3.6 - 5.3

 

 

 Collection time:          Oct 19, 2024@22:02:27

   Test Name                 Result    Units           Range

ALBUMIN                       3.4 L    g/dL        3.6 - 5.3

AST/ASPARTATE AMINOTRANSFERASE  74.20H U/L            8 - 48

ALT / ALANINE AMINOTRANSFERASE  288.0H U/L        7.2 - 21.2

 

 

 Collection time:          Oct 23, 2024@00:25:18

   Test Name                 Result    Units           Range

ALBUMIN                       3.9      g/dL        3.6 - 5.3

SODIUM                     138.30      mmol/L      135 - 145

AST/ASPARTATE AMINOTRANSFERASE 234.00H U/L            8 - 48

ALT / ALANINE AMINOTRANSFERASE  895.0H U/L        7.2 - 21.2

-------------------------------------Assessment---------------------------------

Nutritional status: over weight

====================

.Adequate oral intake.

.Normal albumin level 

.Weight gain 12Kg last 1 year ago 

.Accepted lipid profile 

.No nausea or vomiting

.On amlodipine

 

ICU admission : high blood pressure readings for managment and observation 

|controlled

 

 

RENAL DOPPLER u/s 17/10:

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

---------------------------Nutritional Plan of care-----------------------------

Give: low bacterial, low salt diet 

Limit fatty fried salty food. 

Good hydration is recommended. 




================================================================================
Date: 2024-10-23 13:56
Type: PEDIATRIC PHYSICIAN PROGRESS NOTE
Author: MUQBEL,ROA ABDUL RAZZAQ KHALIL
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
--------------------------------------------------------------------------------

                         ICU ACCEPTANCE NOTE

--------------------------------------------------------------------------------

 

SUMMARY

-------

- Zaher **********-********** is an ********** Year old girl a case of low risk B cell ALL

- status post: off therpay on 12/12/2023

- Admitted as case of combined relapse B-ALL on 16/10

- Transferred to ICU 17-23/10 for elevated blood pressure readings

 

 

----------------Subjective---------------

HNNET:No headache , No earache , No sore throat 

Cardiopulmonary:No cough , No runny nose , no chest pain

GI/Diet:No vomiting, No abdominal pain , no change in bowel habits

Neuromuscular:No pain , no deformity

Genitourinary:No Dysuria , No frequency , no change in urine color or smell

 

 

----------------Objective----------------

-General Condition: cooperative, pleasant, looks well and comfortable, not in 

 distress

-HNNET: No conjunctival pallor, No jaundice, No mouth ulcers, No lymphadenopathy

-Chest: No use of accessory muscles, GAEBL, No wheezes, No crackles 

-Cardiovascular: Normal S1, S2, No murmurs, No added sounds.

-Abdomen: Not distended, soft , no rigidity, no gaurding 

-Musculoskeletal: ambulatory with normal range of motion across joints 

-Skin: No skin lesions, no rash/ petichiae.

 

 

----------------Last Vital signs---------

none today 

 

Pain Score:  0 No pain

 

----------------Intake/output------------

urine output : 2.5 ml/kg/hr

balance:-140 ml

 

---------------Most recent lab-----------

CBC Coll. date         WBC     RBC     HGB     HCT     MCV     MCH     MCHC 

10/23/24 00:25         5.70    4.58                    83.3    28.5    34.2 

 

CBC Coll. date         RDW     PLT     MPV     UNKNOWN UNKNOWN UNKNOWN UNKNOWN 

10/23/24 00:25         15.1 H  101 L   7.0 L 

CREATININE                 10/23/24 00:25    0.4 

POTASSIUM                  10/23/24 00:25    4.47 

ALBUMIN                    10/23/24 00:25    3.9 

 Others: -

 

Cultures: 

-blood culture 19/10: pending 

-blood culture 17/10 :Aerobic culture:No growth after five days of incubation. 

   Anaerobic culture:No growth after five days of incubation 

-stool culture 17/10 :Negative for Salmonella and Shigella 

 

----Radiology during current admission---

 

Brain CT scan with contrast 15/10 : unremarkable 

 

Brain MRI 17/10 : optic nerve swelling 

 

Enal Doppler U/S 17/10 : Hepatosplenomegaly with liver span 14 cm and spleen 

span 14.6 cm. Unremarkable normal renal Doppler scan, no signs of renal artery 

stenosis.

 

Abdominal U/S 22/10 : MILD HEPATOMEGALY 

 

 

------------------Consults---------------

nephrology and cardiology as below

 

-----------------Medications-------------

 

paracetamol oral PRN 

gabapentin  300MG ORAL BID 

 

Keppra      300MG   BID 

Diamox      250MG PO Q12H 

 

amlodipine  2.5 mg q24h 

Inderal     10 mg *3  for SVT

 

Bactrim prophylaxis

 

Histal

 

Dexamethasone 4 mg BID

 

----------------Active Problems----------

Active problems - Computerized Problem List is the source for the following:

 

 1. Leukemia, Lymphocytic  Acute, B-cell  Low Risk   EOI : negative MRD

 2. Syrian refugee  lives in refugee camp 

 3. sever vomiting after anesthesia 

 4. delayed MTX excretion

 5. Pancytopenia  Recurrent Anemia

 6. septic shock ICU admission 

 7. TBNK flow: low

 8. chemosensitivity for workup

 9. Suspected relapse

10. Papilledema 

 

----------Assesment and Plan of care-----

 

SUMMARY

-------

- Z**********er **********-********** is an ********** Year old girl a case of low risk B cell ALL

- status post: off therpay on 12/12/2023

- Admitted as case of combined relapse B-ALL on 16/10

- Transferred to ICU 17-23/10 for elevated blood pressure readings

 

PRESENTATION

============

on 15/10:

- she presented to ER with headache since 1 month that got 

worse today associated with photophobia and unsteady gait. She also has polyurea

 

but no vomiting ,no abdominal pain. She is Afebrile 

- she was found to be hypertense , Brain CT was done:No intracranial 

haemorrhage, midline shift or herniation, Petent dual venous sinuses.

- she was given hydralazine and nephrology consulted :no need to start 

antihypertensive medication to follow up in clinic 

- peripheral flow was sent showed :8 % blast

 

on 16/10 :

- re-presented to ER with same complain 

 

on exam:

--------

- there is sluggish left pupil , limitation in eye movement , multidirectional 

nystagmus , wide based gait , ataxic , can't do tandem gait 

 

 

Consults:

---------

- Opthalmology -> left eye exotropia + limitation on adduction , 

                  has papilledema- treat her increased ICP- 

                  do Brain + Orbit Mri to rule out brain versus orbital 

                  leukemic infiltrtaion is needed

                  diamox dose + steroid is recommended to decrease 

                  intracranial pressure utill the underlying cause resolve 

 

- Nephrology consulted -> start on amlodipine 2.5mg Qday 

                          Renal U/S tomorrow 

 

Medications:

------------

-recieved perflgan , Hydralazine and dexamethasone 4 mg

 => her headache improved 

 

 

Labs:

-----

- CBC : hemoglobin 13.3 , WBC 6.6 , platlets 97 , ANC 2400

- vChesmitry : normal

 

 

so she was admitted to floor on keppra 300 mg*2, diamox 250mg*2 , amlodipine 

2.5mg Qday

 

Brain and orbit MRI done after admission  : FREE AS PRIMARY READING

 

 

## 17/10 :

 

Nephrology wise:

-----------------

-last night she recived 2 hydralazine for high blood pressure reading

-persinstant hypertense regardless hydralazine ( 140s/100s)

-renal ultrasound:

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

""so transferred to PICU to manage high blood pressure reading""

 

 

 

ICU 17-23/10

===============================================

 

oncology : 

----------

17/10 :

- started on dexamethasone PO 8mg/m2 , today is day 7

- has combine relapse :

- Bone marrow biopsy showed : 70% blasts 

- triple IT given , LP done : CNS +

- chemo and 2nd triple IT held due to transaminitis

- Has left eye exotropia + limitation on adduction  , bilateral papilledma 

 

MRI 16/10: optic nerve swelling 

 

 

Respiratory :

--------------

- ON room air  , normal oxygen saturation

- Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

Cardiovascular :

-----------------

- 17/10 : echo : mild mitral valve prolapse with no MR (benign )

 

- 20/10 : developed SVT twice and received one dose of adenosine 

          and Dr. ********** **********h added Inderal 10 mg BID , did not re-occur

 

- Heart rate 100-220

 

- Normal capillary refill

- LINE : periphral 

 

 

Nephrology :

--------------

Blood pressure 100-120/60-70 (95th centile)= 116/77

 

Controlled on :

- Hydralazine 0.2mg/kg/dose q4h prn 

- amlodipine 2.5 mg q24h 

- Inderal 10 mg *3  for SVT

 

Last :

- urine output : 2.5 ml/kg/hr

- balance:-140 ml

 

Renal doppler U/S 17/10 :

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

 

Central nervous system :

------------------------

- CONSCIOUS , ALERT ORIENTED 

- GCS : 15/15 

- left eye exotropia (improved)

 

ON :

paracetamol oral PRN 

gabapentin  300MG ORAL BID 

Keppra      300MG   BID 

Diamox      250MG PO Q12H 

 

- brain ct scan with contrast 15/10 : unremarkable 

- brain MRI 17/10 : optic nerve swelling 

 

 

Gastrointestinal :

-------------------

- She has rising transaminases (ALT>AST) with normal bilirubin and normal 

coagulation profile, glucose, and albumin

 

Trend : 17/10 (167/152) -> 21/10 (711/432) -> 22/10 (954/234)

        -> 23/10 (895/234) Today

 

- Clinically she has hepatomegaly without tenderness. No jaundice. 

 

- Liver U/S 22.Oct.2024: hepatosplenomegaly with no focal lesion 

 

- CMV PCR : 784

 

- Exam : SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

On :

- low bacterial diet 

- nexium 

- IV fluid maintenance 

 

ABDOMINAL U/S 22/10 : MILD HEPATOMEGALY 

 

 

Infectious disease  :

---------------------

- for persisntent tacycardia , septic workup and was started on tazocin and 

amikacin then after 3 days upgraded into meropenem and vancomycin then after 2 

days downgraded into cefepime for 3 days

 

- remained afebrile , currently off antibiotics

 

ON : 

Prohylaxis : Bactrium 

 

Cultures:

-blood culture 19/10: pending 

-blood culture 17/10 : free

-stool culture 17/10 : Negative for Salmonella and Shigella 

 

- CMV PCR POSITIVE : 789 

 

 

PLAN :

========

- observe blood pressure readings 

- check pending cultures 

- chek with primary team according to start chemotherapy

- follow up on LFT

 

------------Nutrition/Diet Plan----------

 low bacterial

 

------------VTE prophylaxis Plan---------

Patient Age < 10 years:NA

 

 

=================================Discharge planning note========================

Reason of admission: combined relapse

 

Estimated length of stay:14 days

 

Goals of Care/needed interventions:

IV antibiotics, Pain Management , Chemotherapy, Consult, Radiology

 

Special Needs upon Discharge

No Special needs

 

Delayed discharge

Yes,Reason delayed chemo




================================================================================
Date: 2024-10-23 10:10
Type: PEDIATRIC PSYCHOLOGIST NOTE
Author: ALKURDI,MAHA OMAR ASHRAF
Location: KHCC-6H-PEDIATRIC
Service: SOCIAL WORK
================================================================================

'
Patient was visited by music therapy as referred by PICU nurse for sadness. 

 

Patient was awake with Grandma present. Patient expressed anger towards Grandma 

and was initially withdrawn and communicated with an aggressive tone. Patient 

expressed emotions through playing musical instruments. Patient's facial 

expression became increasingly sad. She deeply misses her siblings and feels 

very protective and responsible towards them; she thinks they need her. She is 

the oldest sibling. Patient began crying and did not stop, expressing anger and 

sadness. Grandma and nurses shared that this is a frequent occurrance.

 

Patient was referred to clinical psychologist. 




================================================================================
Date: 2024-10-23 09:24
Type: PHYSICIAN CRITICAL CARE NOTE
Author: WAKILEH,ZAID ISSAM AYOUB
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
 

                  PEDIATRIC ICU PROGRESS NOTE 

-----------------------------------------------------------------

 

PROBLEM LIST: 

IS A ********** year old female patient a case of low risk B cell ALL , off therapy 

12/2023 

- bone marrow relapse  ( periphral blood film  8% disease ) 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

 

 

today patient seen and examined 

no new complain .

no nausea or vomiting ( can start oral intake )

was admitted via ER due to high blood pressure readings, on hydralazine and 

amlodipine .

Her Liver enzyme are Elevated 

Cardiac workup, Liver US and  CXR  was done.

 

 

--------------------------------------------------------------------

oncology : 

 

 

- started on dexamethasone PO 8mg/m2 17/10

 

 

- bone marrow relapse  ( periphral flowcytometry  8% disease )

- CNS relapse  ( CSF flowcytometry was consistentt with relapse 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

MRI : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

RESPIRATORY :

ON    room air       , O2 SAT ABOVE 97%

Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

 

-----------------------------------------------------------------------

Cardiovascular :

Heart rate  100-220

Blood pressure 100-120/60-70 (95th centile)= 116/77

NORMAL CAPILARY REFIL 

PALPABLE PERPHRAL PULSES 

 

 

LINE : periphral 

 

HYDRALAZINE 0.2mg/kg/dose q4h prn 

amlodipine 2.5 mg q24h 

Inderal 10 mg *3  for SVT

 

ECHO (17/10):mild mitral valve prolapse with no MR (benign )

 

-----------------------------------------------------------------------

Central nervous system :

CONSCIOUS , ALERT ORIENTED 

GCS : 15/15 

left eye exotropia (improved)

 

ON :

paracetamol oral PRN 

GABAPENTIN  300MG ORAL BID 

levETIRAcetam   300MG   BID 

acetaZOLAMIDE TAB 250MG PO Q12H 

 

brain ct scan with contrast 15/10 : unremarkable 

brain MRI 17/10 : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

Gastrointestinal and renal

 

urine output : 2.5 ml/kg/hr

balance:-140 ml

 

SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

 

- low bacterial diet 

- nexium 

- IV fluid maintenance 

 

 

RENAL DOPPLER u/s 17/10 :

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

ABDOMINAL U/S : 22/10 

MILD HEPATOMEGALY 

 

 

 

----------------------------------------------------------------------

HEMatology /Infectious disease  :

afebrile 

 

ON : 

Prohylaxis : Bactrium 

 

 

-blood culture 19/10: pending 

-blood culture 17/10 :Aerobic culture:No growth after five days of incubation. 

   Anaerobic culture:No growth after five days of incubation 

-stool culture 17/10 :Negative for Salmonella and Shigella 

 

 

CMV PCR POSITIVE 789 

 

----------------------------------------------------------------------

PLAN :

- observe blood pressure readings 

- check pending cultures 

- check official flowcytometry and bone marrow results 

- chek with primary team according to start chemotherapy

 

 




================================================================================
Date: 2024-10-23 06:22
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: AL-KAYED,RANIA HASAN YOUSEF
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     all                                

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     na                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-22 20:00    RA                                            36.50 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     21/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     genral                             

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     na                                 

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     medications                        

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     Gabapentin 300 mg,                 

                                             ,Paracetamol IV 500 mg             

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     PRN                                

  2024-10-22 20:00    RA                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     pain                               

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 20:00    RA                     0                                  

  2024-10-23 00:00    RA                     0                                  

  2024-10-23 04:00    RA                     0                                  

  2024-10-23 06:00    RA                     0                                  

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 




================================================================================
Date: 2024-10-22 19:12
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: MUSLEH,LUJAIN ATWAN MAHMOUD
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     ALL                                

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     NA                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-22 08:00    LM                                            37.00 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     22.20.2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     general                            

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     Throb                              

  2024-10-22 08:00    LM                     Pressure                           

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     rest and medcations                

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     Gabapentin 300 mg                  

                                             ,Paracetamol IV 500 mg             

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     PRN                                

  2024-10-22 08:00    LM                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     IV                                 

  2024-10-22 08:00    LM                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     to decrease pain level less        

                                             than 4/10                          

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     0/10                               

  2024-10-22 12:00    LM                     0/10                               

  2024-10-22 16:00    LM                     0/10                               

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     0=Alert                            

  2024-10-22 12:00    LM                     0=Alert                            

  2024-10-22 16:00    LM                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-22 08:00    LM                     NA                                 

  2024-10-22 12:00    LM                     NA                                 

  2024-10-22 16:00    LM                     NA                                 

 

 

 

 




================================================================================
Date: 2024-10-22 11:15
Type: PHYSICIAN CRITICAL CARE NOTE
Author: SALEEM,MOHAMMAD SALEEM MAHMOUD
Location: KHCC-6H-PEDIATRIC
Service: BONE MARROW TRANSPLANTATION
================================================================================

'
                  PEDIATRIC ICU PROGRESS NOTE 

-----------------------------------------------------------------

 

PROBLEM LIST: 

IS A ********** year old female patient a case of low risk B cell ALL , off therapy 

12/2023 

- bone marrow relapse  ( periphral blood film  8% disease ) 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

 

 

today patient seen and examined 

no new complain .

no nausea or vomiting ( can start oral intake )

yesterday patient developed one attack of SVT , received one dose of adenosine 

. although she recived one dose of Inderal.

was admitted via ER due to high blood pressure readings, on hydralazine and 

amlodipine .

Her Liver enzyme are Elevated 

Cardiac workup, Liver US and  CXR  was done.

 

 

--------------------------------------------------------------------

oncology : 

 

 

- started on dexamethasone PO 8mg/m2 17/10

 

 

- bone marrow relapse  ( periphral flowcytometry  8% disease )

- CNS relapse  ( CSF flowcytometry was consistentt with relapse 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

MRI : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

RESPIRATORY :

ON    room air       , O2 SAT ABOVE 97%

Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

 

-----------------------------------------------------------------------

Cardiovascular :

Heart rate  100-220

Blood pressure 100-120/60-70 (95th centile)= 116/77

NORMAL CAPILARY REFIL 

PALPABLE PERPHRAL PULSES 

 

 

LINE : periphral 

 

HYDRALAZINE 0.2mg/kg/dose q4h prn 

amlodipine 2.5 mg q24h 

Inderal 10 mg BID for SVT

 

ECHO (17/10):mild mitral valve prolapse with no MR (benign )

 

-----------------------------------------------------------------------

Central nervous system :

CONSCIOUS , ALERT ORIENTED 

GCS : 15/15 

left eye exotropia (improved)

 

ON :

paracetamol oral PRN 

GABAPENTIN  300MG ORAL BID 

levETIRAcetam   300MG   BID 

acetaZOLAMIDE TAB 250MG PO Q12H 

 

brain ct scan with contrast 15/10 : unremarkable 

brain MRI 17/10 : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

Gastrointestinal and renal

 

urine output : 2.2 ml/kg/hr

balance:+360 ml

 

SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

 

- low bacterial diet 

- nexium 

- IV fluid maintenance 

 

 

RENAL DOPPLER u/s 17/10 :

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

 

 

----------------------------------------------------------------------

HEMatology /Infectious disease  :

afebrile 

 

ON :

Cefipime Day 3 

Prohylaxis : Bactrium 

 

OFF:

meropenem day 2 

vancomycin day 2 

 

blood culture 19/10: pending 

blood culture 17/10 : pending 

stool culture 17/10 : pending 

 

 

 

 

----------------------------------------------------------------------

PLAN :

- observe blood pressure readings 

- check pending cultures 

- check official flowcytometry and bone marrow results 

- chek with primary team according to start chemotherapy

- observe in picu for another day . 

- GI consult 

- Consider PICC line insertion.




================================================================================
Date: 2024-10-22 06:03
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: AL-KAYED,RANIA HASAN YOUSEF
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     all                                

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     na                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-21 20:00    RA                                            37.00 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     18/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     general                            

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     Pressure                           

  2024-10-21 20:00    RA                     Cramp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     SUDDEN ONSET                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     na                                 

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     medications                        

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     paracetamol  500 mg                

                                             ,gabapentin 300 mg                 

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     PRN                                

  2024-10-21 20:00    RA                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     IV                                 

  2024-10-21 20:00    RA                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     pain                               

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-21 20:00    RA                     0                                  

  2024-10-22 00:00    RA                     0                                  

  2024-10-22 04:00    RA                     0                                  

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

 

 

 

 

 

 

 

 




================================================================================
Date: 2024-10-21 15:40
Type: LEUKEMIA MDC NOTE
Author: AHMED,HIBA EMADELDEEN ABDELSAMAD
Location: KHCC-6H-PEDIATRIC
Service: INTERNAL MEDICINE
================================================================================

'
patient name:**********  patient ID:**********

patient age:**********yr **********mo    patient DOP:**********

patient sex:FEMALE

--------------------------------------------------------------------------------

                                 Pediatric Leukemia

                          Multidisciplinary Clinic Form

--------------------------------------------------------------------------------

MDC Date:Oct 21,2024

 

case summary

**********aher Al********** is an 8 Year 9 months old Syrian girl, case of low risk B cell 

ALL, completed therpay on 12/12/2023

Presented to clinic on 15/10/2024 , complain of severe lower limb pain ,

polyuria and polydepsia , Abnormal behaviour and high blood pressure

upon assessment 

she is consious , oriented GCS 15/15

but she has wide base gait

and Left eye Nystagmus 

seen by opthalmologist , they reported papilledema

 

- She was admitted to PICU on 16/10/2024 for BP control

 

- CSF Cytology : many blast seen

- bone marrow evaluation : B lymphoblastic leukemia in relapse 

- Flowcytometry : 86% of cells are B lymphoblastic leukemia 

- ALT 711  AST 432

 

On 19/10/2024 she developed SVT , treated by Adenosine

 

Started on dexamethasone  8mg/m2 17/10

 

Issue for discussion :

Relapsed B cell ALL for management plan

 

MDC Decision :

Planned to proceed for Re-induction of remission per R16 protocol if labs 

acceptable

 




================================================================================
Date: 2024-10-21 11:59
Type: PHYSICIAN CRITICAL CARE NOTE
Author: SALEEM,MOHAMMAD SALEEM MAHMOUD
Location: KHCC-6H-PEDIATRIC
Service: BONE MARROW TRANSPLANTATION
================================================================================

'
                  PEDIATRIC ICU PROGRESS NOTE 

-----------------------------------------------------------------

 

PROBLEM LIST: 

IS A ********** year old female patient a case of low risk B cell ALL , off therapy 

12/2023 

- bone marrow relapse  ( periphral blood film  8% disease ) 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

 

 

today patient seen and examined 

no new complain .

no nausea or vomiting ( can start oral intake )

yesterday patient developed one attack of SVT , received one dose of adenosine 

.and SVT did not recurre .

was admitted via ER due to high blood pressure readings, on hydralazine and 

amlodipine .

Dr. ********** **********h add Inderal 10 mg BID for svt 

As part of tachycardia developed , culture was taken and antibiotics upgraded . 

chemotherapy was discussed with oncology and the primary team . Dr. **********ad 

decided to give TIT . And the rest of chemotherapy.

 

--------------------------------------------------------------------

oncology : 

 

 

- started on dexamethasone  8mg/m2 17/10

 

 

- bone marrow relapse  ( periphral flowcytometry  8% disease )

- CNS relapse  ( CSF flowcytometry was consistentt with relapse 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

MRI : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

RESPIRATORY :

ON    room air       , O2 SAT ABOVE 97%

Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

 

-----------------------------------------------------------------------

Cardiovascular :

Heart rate  120-140 

Blood pressure 100-120/60-70 (95th centile)= 116/77

NORMAL CAPILARY REFIL 

PALPABLE PERPHRAL PULSES 

 

 

LINE : periphral 

 

HYDRALAZINE 0.2mg/kg/dose q4h prn 

amlodipine 2.5 mg q24h 

Inderal 10 mg BID

 

ECHO (17/10):mild mitral valve prolapse with no MR (benign )

 

-----------------------------------------------------------------------

Central nervous system :

CONSCIOUS , ALERT ORIENTED 

GCS : 15/15 

left eye exotropia (improved)

 

ON :

paracetamol oral PRN 

GABAPENTIN  300MG ORAL BID 

levETIRAcetam   300MG   BID 

acetaZOLAMIDE TAB 250MG PO Q12H 

 

brain ct scan with contrast 15/10 : unremarkable 

brain MRI 17/10 : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

Gastrointestinal and renal

 

urine output : 4 ml/kg/hr

balance:+960 ml

 

SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

 

- low bacterial diet 

- nexium 

- IV fluid maintenance 

 

 

RENAL DOPPLER u/s 17/10 :

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

 

 

----------------------------------------------------------------------

HEMatology /Infectious disease  :

afebrile 

 

ON :

Cefipime Day 1 

 

OFF:

meropenem day 2 

vancomycin day 2 

 

blood culture 19/10: pending 

blood culture 17/10 : pending 

stool culture 17/10 : pending 

 

 

 

 

----------------------------------------------------------------------

PLAN :

- observe blood pressure readings 

- check pending cultures 

- check official flowcytometry and bone marrow results 

- chek with primary team according to start chemotherapy

- observe in picu for another day . 

 




================================================================================
Date: 2024-10-21 11:17
Type: LEUKEMIA MDC NOTE
Author: KANAAN,DANA SAEED AHMAD
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
 

**********C Leukemia note :21/10/2024

 

MDC DATE :21/10

 

Diagnosis : 

Relapse B-ALL  combined CNS , BM Relapse 

 

CYTOGENITICS / MOLECULAR STUDIES :

Pending 

 

case summary : 

- ********** year old female patient , case of B cell ALL

- status post: off therapy on 12/12/2023

on 15/10:

- she presented to ER with headache since 1 month that got 

worse today associated with photophobia and unsteady gait. She also has polyurea

 

but no vomiting ,no abdominal pain. She is Afebrile 

- she was found to be hypertense , Brain CT was done:No intracranial 

haemorrhage, midline shift or herniation, Petent dual venous sinuses.

- she was given hydralazine and nephrology consulted :no need to start 

antihypertensive medication to follow up in clinic 

- Blood film was sent showed :8 % blast

-BM asprate and biopsy : showed relapse 80% B-CELL ALL 

- bone marrow relapse  ( periphral flowcytometry  8% disease )

 

- CNS relapse  ( CSF flowcytometry was consistentt with relapse 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation .

 

MRI : optic nerve swelling 

 

- started on dexamethasone  8mg/m2 17/10

 

 

 

MDC decision :

start chemotherapy per KHCC CPG for B-ALL , start RE-INDUCTION BY R16 PROTOCOL 




================================================================================
Date: 2024-10-21 06:52
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: AYAAD,FARH FARAJ HASAN
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     relapsed ALL                       

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     NA                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-20 20:00    FA                                            34.50 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     18.10.2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     general , bone pain                

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     Throb                              

  2024-10-20 20:00    FA                     Sharp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     SUDDEN ONSET                       

  2024-10-20 20:00    FA                     Intermittent                       

  2024-10-20 20:00    FA                     OCCURS WITH MOVEMENT               

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     rest , medications                 

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     paracetamol 500 mg ,               

                                             gabapentin 300 mg                  

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     PRN                                

  2024-10-20 20:00    FA                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     IV                                 

  2024-10-20 20:00    FA                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     to decrease level of pain          

                                             below (4/10).                      

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     0/10                               

  2024-10-21 00:00    FA                     0/10                               

  2024-10-21 04:00    FA                     0/10                               

  2024-10-21 06:00    FA                     0/10                               

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:23    FA                     gabaoentin 300 mg po               

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     0=Alert                            

  2024-10-21 00:00    FA                     S=Normal Sleep                     

  2024-10-21 04:00    FA                     S=Normal Sleep                     

  2024-10-21 06:00    FA                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 20:00    FA                     NA                                 

  2024-10-21 00:00    FA                     NA                                 

  2024-10-21 04:00    FA                     NA                                 

  2024-10-21 06:00    FA                     NA                                 

 

 

 

 

 

 

 




================================================================================
Date: 2024-10-20 19:13
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: ZAHRAN,ASEEL KHALED MOHAMMAD
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     relapsed ALL                       

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     NA                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-20 08:00    AZ                                            34.50 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     18/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     general                            

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     Throb                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     SUDDEN ONSET                       

  2024-10-20 08:00    AZ                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     with movoment                      

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     with rest and pain mediation       

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     Paracetamol 500 mg                 

  2024-10-20 08:00    AZ                     Gabapentin 300 mg                  

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     PRN                                

  2024-10-20 08:00    AZ                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     IV                                 

  2024-10-20 08:00    AZ                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     for pain more than 4               

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     0/10                               

  2024-10-20 12:00    AZ                     0/10                               

  2024-10-20 16:00    AZ                     0/10                               

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     S=Normal Sleep                     

  2024-10-20 12:00    AZ                     0=Alert                            

  2024-10-20 16:00    AZ                     S=Normal Sleep                     

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-20 08:00    AZ                     NA                                 

  2024-10-20 12:00    AZ                     NA                                 

  2024-10-20 16:00    AZ                     NA                                 

 

 

 

 




================================================================================
Date: 2024-10-20 15:07
Type: Nutrition Pediatric  Assessment
Author: KHALAF,ZAIN MOHAMMAD MUSTAFA
Location: KHCC-6H-PEDIATRIC
Service: NUTRITION
================================================================================

'
--------------------------------------------------------------------------------

                        Pediatric Nutrition Assessment Note

--------------------------------------------------------------------------------

Allergy:ALLERGIES/ADVERSE REACTIONS - NONE FOUND

--------------------------------------------------------------------------------

Problems:

Active problems - Computerized Problem List is the source for the following:

 

 1. Leukemia, Lymphocytic                             02/06/22  MSAMEH,ALAA **********S

 2. Syrian refugee                                    02/06/22  ZANDAKI,DUAA AHM

 3. sever vomiting after anesthesia                   05/25/21  ALSHATHLY,MUHANA

 4. delayed MTX excretion                             05/25/21  ALSHATHLY,MUHANA

 5. Pancytopenia                                      02/06/22  HAJJIR,HALA AHMA

 6. septic shock ICU admission                        11/14/21  GUZU,TASNEEM ALI

 7. TBNK flow: low                                    02/06/22  BUDAIR,RAWAN NOU

 8. chemosensitivity for workup                       04/03/22  ZANDAKI,DUAA AHM

 9. Suspected relapse                                 10/17/24  MUQBEL,ROA ABDUL

10. Papilledema                                       10/17/24  MUQBEL,ROA ABDUL

--------------------------------------------------------------------------------

Diagnosis:  B cell ALL

--------------------------------------------------------------------------------

Reason of Admission: 

admitted to pediatric intensive care unit due to observation for (hypertension)

--------------------------------------------------------------------------------

Current treatment modality:

 - status post: off therapy on 12/12/2023

--------------------------------------------------------------------------------

Oral Intake:Adequate (more than 60% of the total caloric requirements)

--------------------------------------------------------------------------------

Current Weight:34.5Kg        Height:134cm      BMI: 19.2

BMI/Age:********** 

The Patient is:Over Weight

 

Previous documented weight

10/16/24 @ 1810     WEIGHT: 76.06 lb. ( 34.57 kg.)

 

Ideal Body weight:29Kg

Weight /ideal body weight:119%

Weight /age:84%              height/age: 65% 

Total daily caloric requirement: 1800 kcal/d.

Total daily Protein requirement: 72   g/d.

-----------------------------Investigation--------------------------------------

Lipid profile:LIPID PROFILE Coll. datCHOL    TRIG    HDL     LDL

1/16/24 10:47                        123.00  70.60   47.70   61 

 

  Collection time:          Oct 17, 2024@00:07:29

   Test Name                 Result    Units           Range

ALBUMIN                       4.4      g/dL        3.6 - 5.3

 

 

 Collection time:          Oct 19, 2024@22:02:27

   Test Name                 Result    Units           Range

ALBUMIN                       3.4 L    g/dL        3.6 - 5.3

AST/ASPARTATE AMINOTRANSFERASE  74.20H U/L            8 - 48

ALT / ALANINE AMINOTRANSFERASE  288.0H U/L        7.2 - 21.2

-------------------------------------Assessment---------------------------------

Nutritional status: over weight

====================

.Adequate oral intake, consumed her breakfast meal today. 

.Low albumin level 

.Weight gain 12Kg last 1 year ago 

.Accepted lipid profile 

.No nausea or vomiting

 

ICU admission : high blood pressure readings for managment and observation 

|controlled

 

 

RENAL DOPPLER u/s 17/10:

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

---------------------------Nutritional Plan of care-----------------------------

Patient's father was educated about: high protein diet 

Limit fatty fried salty food. 

Good hydration is recommended. 




================================================================================
Date: 2024-10-20 15:05
Type: LR SURGICAL PATHOLOGY REPORT
Author: BARAKAT,FAREED HANI FAREED
Location: KHCC-6H-PEDIATRIC
Service: LABORATORY
================================================================================

'
$APHDR

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Laboratory: KING **********USSEIN CANCER CENTER

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

 

SURGICAL PATH DIAGNOSIS:

     CLINICAL HISTORY: 

      A case of  B-ALL.  

      

     TISSUE ORIGIN:  

      Bone marrow aspirate and biopsy.  

      

     PERIPHERAL BLOOD: 

      Red blood cells: Normochromic normocytic.   

      White blood cells: Many blasts seen. 

      Platelets: Slightly decreased.  

      

     ASPIRATE: 

      Quality: Aspicular.  

      Granulocyte:  Suppressed maturation.  

      Erythrocytes:  Normoblastic maturation.  

      Megakaryocytes: Not seen.  

      Blasts: Increased 70%.  

      Iron stores: Cannot be assessed due to lack of particles.  

      

     BIOPSY: 

      Measurement: One core, the longest measures 2cm.  

      Quality: Adequate.  

      Cellularity:  99%.  

      Granulocyte: Decreased.  

      Erythrocytes: Decreased.  

      Megakaryocytes: Decreased.  

      Blasts: Increased 90%. 

      

      

     FINAL DIAGNOSIS:  

      

     BONE MARROW, ASPIRATE AND BIOPSY, UNILATERAL: 

      B-Lymphoblastic leukemia, relapse. See note. 

      

      

     NOTE: 

      Flow cytometry is consistent with the above diagnosis.  

      

      

      

     ********** **********, M.D.  

      

      

     ********** ********** **********t, M.D. FASCP.  Surgical/Molecular/Hematopathologist.  

 

/es/ FAREED **********RAKAT MD

 

Signed OCT 20, 2024@15:05:47




================================================================================
Date: 2024-10-20 14:19
Type: PSYCHOSOCIAL ASSESSMENT (PEDIATRIC)
Author: ALWARAYDAT,TAMARA ADEL NADI
Location: KHCC-6H-PEDIATRIC
Service: SOCIAL WORK
================================================================================

'
                   PSYCHOSOCIAL ASSESSMENT COMPREHANSIVE (Pediatric)

------------------------------------------------------------------------------- 

Assessment Date:Oct 20,2024

Inpatient

                         Identifying Information

-------------------------------------------------------------------------------

Patient Name : **********

Source of information:Relatives

                             Demographics

--------------------------------------------------------------------------------

 

Diagnosis:suspected relapsed ALL, 

Pay modality:Good Well Fund

Insurance Type:Goodness boxes

Religion:Muslim

Nationality:Non **********ianSyrian

Parent Martial Status: Married

                          Education

--------------------------------------------------------------------------------

Educational Level:Primary schoolGrad3

Other(define):

--------------------------------------------------------------------------------

Parent Education/Employment

--------------------------------------------------------------------------------

 

 

Father:

Educational Level:Secondary school

Employment: works in construction

Mother:

Educational Level:Secondary school

Employment: 

Care Givers

Educational Level:

Employment: 

                        Housing/Living

--------------------------------------------------------------------------------

Address:

      Governorate: **********arqaOthers

      Area:       Ghwareiah

      Neighborhood

      Building#: 

Contact Information:

      Phone Number:**********

 

 

 

Housing Status:Apartmentrented

Living with:  Parents

Number of persons in household: 7 

 

* Brothers   2  * Sisters2

* Ants   0      * Uncles   0

* Grandparent:0

 

Ages of siplings:

*0-6   3    *7-12  1

* 13-18 0  *18 - 24 0 * 24+0

 

Detailed Family History(out of home)

Parent:0 Sister:0 Brothers:0

Ants:6   Uncles:4

Grandparent:2 Others:0

                             Social History

--------------------------------------------------------------------------------

             PATIENT              I       FAMILY 

                                   I 

Smoking      [NO]               I Smoking          [YES] 

Drug         [NO]               I Drug             [NO]

Alcohol      [NO]               I Alcohol          [NO]

Mental Ilness[NO]               I Mental Ilness    [NO]

Disability   [NO]               I Disability       [NO]

Suicide      [NO]               I Family abuse     [NO]

If patient is suicidal I Family neglect   [NO]

 

                      RELATIONSHIP     OTHER REMARKS

Primary Care Givier 

 I 

 I 

 I 

                        Distress Thermometer scale

--------------------------------------------------------------------------------

Directions:

From(0-10)(0 no distress 10 extreme distress).

How much distress you have been experiencing in the past week including today?

4

-------------------------------------------------------------------------------

Referring Service:Pediatric

Location/Floor:WARD LOC - **********HCC-**********H-PEDIATRIC ICU 

--------------------------------------------------------------------------------

                         Detailed distress assessment

--------------------------------------------------------------------------------

Physical Concerns

                            Yes/No   I   If any,refer to PsychoSocial services 

Pain                        [YES]  I  For nursing

Sleep                       [NO]  I 

Fatigue                     [YES]  I 

Tobacco use                 [NO]  I 

Substance use               [NO]  I 

Memory/Concentration        [NO]  I 

Sexual health               [NO]  I 

Changes in eating           [NO]  I 

Loss/change of physical

abilities                   [YES]  I 

Emotional Concerns

                            Yes/No   I   If yes,referral to Social work services

Worry or anxiety            [NO]  I 

Sadness or depression       [YES]  I 

loss of interest/enjoyment  [NO]  I 

Grief or loss               [NO]  I 

Fears                       [NO]  I 

Loneliness                  [NO]  I 

Anger                       [YES]  I 

Changes in appearance       [NO]  I 

Feeling of worthlessness 

or being a burden           [NO]  I 

Social Concerns

                            Yes/No   I   If yes,referral to Social work services

Relationship with 

spouse/partner              [NO]  I 

Relationship with children  [NO]  I 

Relationship with family    [NO]  I 

Relationship with

 friends/coworkers          [NO]  I 

Communication with 

 health care team           [NO]  I 

Ability to have children    [NO]  I 

Practical Problems 

                            Yes/No   I   If any,refer to PsychoSocial services 

Taking care of myself       [YES]  I 

Taking care of others       [YES]  I 

Work                        [NO]  I 

School                      [NO]  I 

Housing                     [NO]  I 

Finances                    [YES]  I 

Insurance                   [NO]  I 

Transportation              [NO]  I 

Child care                  [NO]  I 

Having enough food          [NO]  I 

Access to medicine          [NO]  I 

Treatment decisions         [NO]  I 

Spiritiual/religious concerns

                            Yes/No   I    If any,refer to PsychoSocial services

Sense of meaning or purpose [NO]  I 

Changes in faith or beliefs [NO]  I 

Death, dying or afterlife   [NO]  I 

Conflict between beliefs 

and cancer treatments       [NO]  I 

Relationship with God       [NO]  I 

Ritual or dietary           [NO]  I 

Other concerns

                            Yes/No   I  If yes,psychologist referral family 

                                            counseling

Abuse or neglect            [NO]  I 

Suicidal Ideation or attempt[NO]  I 

 

Ask the patient if he needs anything else: 

 

Ask the patient if he needs from us today: 

Patient Health Questionnaire:

The four-item patient health questionnaire for anxiety and depression

 

Over the last two weeks, how often have you been bothered by the following 

problems? 

 

Feeling nervous, anxious or on edge          0 Not at all

Not being able to stop or control worrying   1 Several days 

Feeling down, depressed or hopeless          1 Several days 

Little interest or pleasure in doing things  1 Several days 

 

TOTALS 3

                        High Risk family Assessment

--------------------------------------------------------------------------------

High Risk family: Family lives far and/or underserved situation, poor financial 

support

High Risk family:if patient meets one or more of the above high risk 

criteria:Yes 

                        Immediate Concern or Goals

--------------------------------------------------------------------------------

Immediate concern or goals (as stated by patient and family)

                           Action Plan

--------------------------------------------------------------------------------

Social Services:

 We talked a 

little, and emotional and psychological support was provided 

through active listening. I also allowed her to express her 

thoughts, feelings, and fears, and taught her breathing exercises 

to help her cope with her anger. Additionally, I provided her 

with some dry clay and stories to fill her free time.

 

Financial screening:

Finanital treatment coverage

Psychology Servies

Psychology referral

----------------------------social worker discharge action plan-----------------

Patient need assistance with daily life activities?No

 If Yes Specify 

patient need education or training? No

 If Yes Specify 

Patient Need companion:  Yes

 If Yes Specify 

Patient Need medical equipment/supplies/services No

 If Yes Specify: 

Patient Have Previous Admissions: Yes

Items Not included in the insurance: 

Suggestion to improve: 

**********hrs:

The patient is an **********-year-and-**********-month-old girl from **********, 

residing in ********** since **********. She lives in **********qa with her family 

and has two brothers and two sisters, making her the oldest 

sibling, while the youngest is 4 months old. Her father works in 

construction, and her mother is a homemaker. Her grandfather 

accompanies her during her visits to the center since her father 

is at work and her mother is taking care of her siblings.

 

Her maternal relatives are in **********, while her paternal relatives 

live in the same building. The patient has a strong bond with her 

siblings and wishes to return home to play with them. She is in 

the third grade and used to attend school regularly before her 

health deteriorated.

 

She was lying in bed, alert, aware, and upset. We talked a 

little, and emotional and psychological support was provided 

through active listening. I also allowed her to express her 

thoughts, feelings, and fears, and taught her breathing exercises 

to help her cope with her anger. Additionally, I provided her 

with some dry clay and stories to fill her free time.




================================================================================
Date: 2024-10-20 13:25
Type: PHYSICIAN CRITICAL CARE NOTE
Author: WAKILEH,ZAID ISSAM AYOUB
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
PEDIATRIC ICU PROGRESS NOTE 

-----------------------------------------------------------------

 

PROBLEM LIST: 

IS A ********** year old female patient a case of low risk B cell ALL , off therapy 

12/2023 

- bone marrow relapse  ( periphral blood film  8% disease ) 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

 

 

today patient seen and examined 

no new complain .

no nausea or vomiting ( can start oral intake )

yesterday patient developed one attack of SVT , received one dose of adenosine 

.and SVT did not recurre .

was admitted via ER due to high blood pressure readings, on hydralazine and 

amlodipine .

As part of tachycardia developed , culture was taken and antibiotics upgraded . 

chemotherapy was discussed with oncology and the primary team . we decided to 

posponed TIT . And the rest of chemotherapy , till we check the official result 

of bonemarrow . 

 

 

--------------------------------------------------------------------

oncology : 

 

 

- started on dexamethasone  8mg/m2 17/10

 

 

- bone marrow relapse  ( periphral flowcytometry  8% disease )

- CNS relapse  ( CSF flowcytometry was consistentt with relapse 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

MRI : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

RESPIRATORY :

ON    room air       , O2 SAT ABOVE 97%

Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

 

-----------------------------------------------------------------------

Cardiovascular :

Heart rate  120-140 

Blood pressure 100-120/60-70 (95th centile)= 116/77

NORMAL CAPILARY REFIL 

PALPABLE PERPHRAL PULSES 

 

 

LINE : periphral 

 

HYDRALAZINE 0.2mg/kg/dose q4h prn 

amlodipine 2.5 mg q24h 

 

ECHO (17/10):mild mitral valve prolapse with no MR (benign )

 

-----------------------------------------------------------------------

Central nervous system :

CONSCIOUS , ALERT ORIENTED 

GCS : 15/15 

left eye exotropia (improved)

 

ON :

paracetamol PRN 

GABAPENTIN  300MG ORAL BID 

levETIRAcetam   300MG   BID 

acetaZOLAMIDE TAB 250MG PO Q12H 

 

brain ct scan with contrast 15/10 : unremarkable 

brain MRI 17/10 : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

Gastrointestinal and renal

 

urine output : 4.1 ml/kg/hr

balance:+270 ml

 

SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

 

- low bacterial diet 

- nexium 

- IV fluid maintenance 

 

 

RENAL DOPPLER u/s 17/10 :

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

 

 

----------------------------------------------------------------------

HEMatology /Infectious disease  :

afebrile 

 

ON :

meropenem day 1-2 

vancomycin day 1-2 

 

blood culture 19/10: pending 

blood culture 17/10 : pending 

stool culture 17/10 : pending 

 

 

 

 

----------------------------------------------------------------------

PLAN :

- observe blood pressure readings 

- check pending cultures 

- check official flowcytometry and bone marrow results 

- chek with primary team according to start chemotherapy

- observe in picu for another day . 

 




================================================================================
Date: 2024-10-20 06:46
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: AYAAD,FARH FARAJ HASAN
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     relapsed ALL                       

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     NA                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-19 20:00    FA                                            34.50 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     18/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     general                            

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     Throb                              

  2024-10-19 20:00    FA                     Sharp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     SUDDEN ONSET                       

  2024-10-19 20:00    FA                     Intermittent                       

  2024-10-19 20:00    FA                     OCCURS WITH MOVEMENT               

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     rest , medications                 

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     Paracetamol 500 mg                 

                                             ,Gabapentin 300 mg .               

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     PRN                                

  2024-10-19 20:00    FA                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     IV                                 

  2024-10-19 20:00    FA                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     to decrease level of pain          

                                             below (4/10).                      

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     5/10                               

  2024-10-20 00:00    FA                     0/10                               

  2024-10-20 04:00    FA                     0/10                               

  2024-10-20 06:00    FA                     0/10                               

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:30    FA                     0/10                               

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     paracetamol 500 mg iv              

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     GABAPENTIN CAP 300 mg po           

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     0=Alert                            

  2024-10-20 00:00    FA                     0=Alert                            

  2024-10-20 04:00    FA                     0=Alert                            

  2024-10-20 06:00    FA                     S=Normal Sleep                     

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 20:00    FA                     NA                                 

  2024-10-20 00:00    FA                     NA                                 

  2024-10-20 04:00    FA                     NA                                 

  2024-10-20 06:00    FA                     NA                                 

 

 

 

 

 




================================================================================
Date: 2024-10-19 18:37
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: LAFI,BUSHRA RASHAD A.
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     ALL                                

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     NA                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-19 08:00    NG                                            34.50 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     18/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     Back                               

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     Other                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     SUDDEN ONSET                       

  2024-10-19 08:00    NG                     Constant                           

  2024-10-19 08:00    NG                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     rest,medications                   

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     Gabapentin 300 mg,                 

                                             paracetamol 500 mg                 

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     PRN                                

  2024-10-19 08:00    NG                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     IV                                 

  2024-10-19 08:00    NG                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     To relief pain                     

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     0/10                               

  2024-10-19 12:00    BL                     0/10                               

  2024-10-19 16:00    BL                     0/10                               

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     Gabapentin 300 mg                  

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     0=Alert                            

  2024-10-19 12:00    BL                     0=Alert                            

  2024-10-19 16:00    BL                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-19 08:00    NG                     NA                                 

  2024-10-19 12:00    BL                     NA                                 

  2024-10-19 16:00    BL                     NA                                 

 

 




================================================================================
Date: 2024-10-19 14:39
Type: CLINICAL PHARMACIST NOTE
Author: EL NIMER,BAYAN OSAMA ADEL
Location: KHCC-6H-PEDIATRIC
Service: PHARMACY
================================================================================

'
Patient Name: **********

Patient ID: **********-00-48145

Patient Age: **********yr **********mo

Patient Sex: FEMALE

Weight: 76.06 lb [34.6 kg] (10/16/2024 18:10)

Height: 52.756 in [134.0 cm] (10/16/2024 18:10)

Allergies: Patient has answered NKA

Active Inpatient Medications (including Supplies):

 

     Active Inpatient Medications                           Status

=========================================================================

1)   AMIKACIN INJ,SOLN AMIKACIN 700 MG in SODIUM CHLORIDE   ACTIVE

       0.9% 140 ML  INFUSE OVER 30 Minutes IV Q24H

2)   DEXTROSE 5%/SODIUM CHLORIDE 0.9% INJ,SOLN in DEXTROSE  ACTIVE

       5%/NACL 0.9% [D] 500 ML  75 ml/hr IV

3)   ESOMEPRAZOLE INJ,PWDR  20MG IV Q24H                    ACTIVE

4)   GABAPENTIN CAP,ORAL  300MG PO BID                      ACTIVE

5)   LORATADINE TAB,ORAL  10MG PO QDAY                      ACTIVE

6)   NYSTATIN SUSP,ORAL  100000UNIT/1ML PO TID SWISH AND    ACTIVE

       SWALLOW

7)   PARACETAMOL INJ  500 MG IV Q6H PRN 15mg/kg fever or    ACTIVE

       pain

8)   PIPERACILLIN/TAZOBACTAM INJ                            ACTIVE

       PIPERACILLIN/TAZOBACTAM 3500 MG in SODIUM CHLORIDE

       0.9% 50 ML  INFUSE OVER 30 Minutes IV Q6H

9)   POVIDONE IODINE SOLN,TOP  AS DIRECTED POVIDONE IODINE  ACTIVE

       10% SOLN 120ML TOP TID

10)  SODIUM BICARBONATE MOUTHWASH  5 ML PO TID SWISH AND    ACTIVE

       SPLIT

11)  ZINC OXIDE PASTE  A SAMLL AMOUNT TOP TID ON PERIANAL   ACTIVE

       AREA

12)  acetaZOLAMIDE TAB  250MG PO BID 15mg/kg                ACTIVE

13)  amLODIPine TAB  2.5 MG PO QDAY as per nephro plan      ACTIVE

14)  dexAMETHasone INJ,SOLN DEXAMETHASONE 4 MG in DEXTROSE  ACTIVE

       5% 50 ML  INFUSE OVER 30 Minutes IV Q12H

15)  hydrALAZINE INJ,SOLN hydrALAZINE 6 MG in NORMAL        ACTIVE

       SALINE SYRINGE 0.3 ML  INFUSE OVER 20 MINUTES

       0.2mg/kg IV Q4H PRN

16)  levETIRAcetam SOLN  300MG PO BID ppx 20mg/kg/day       ACTIVE

=============================================================================

 

 

 An 8 years ********** months old girl, known case of low risk B cell ALL, off therapy 

since December 2023. Presented to the clinic complaining of headache, polyuria 

and polydipsia, then she presented to the ER with worsening headache, 

photophobia, nystagmus, and was hypertensive. Transferred to the PICU with high 

blood pressure readings for management and observation.

 

 

 She was Started on Amlodipine and Hydralazine as needed q4h for elevated blood 

pressure, was planned for transfer to floor after her blood pressure stabilized,

 

then she developed supraventricular tachycardia, Adenosine given, cardiologist 

consulted, no plan to add any medication.

 When she developed tachycardia, cultures sent and started empirically on 

Piperacillin/Tazobactam  and Vancomycin, to be re-evaluated after final report 

of the cultures.

 

 She had an elevated intracranial pressure for which she was started on 

Acetazolamide, Dexamethasone and prophylactic levetiracetam

 

Medications were reviewed and assessed.

Recommendations: none

 

 

 




================================================================================
Date: 2024-10-19 09:45
Type: PHYSICIAN CRITICAL CARE NOTE
Author: ANABTAWI,LAMIA SAMIR MOHAMMAD
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
PEDIA**********IC ICU PROGRESS NOTE 

-----------------------------------------------------------------

 

PROBLEM LIST: 

IS A ********** year old female patient a case of low risk B cell ALL , off therapy 

12/2023 

- bone marrow relapse  ( periphral blood film  8% disease ) 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

 

 

ICU course : 

presented through emergency department with high blood pressure readings 150/100

 

, abnormal eye movements

- periphral flowcytometry showed 8% blasts. 

-admitted to pediatric floor for observation and managment of blood pressure 

readings , dr edward was consulted plan was to start her on amlodipine and 

hydralazine PRN 

- brain CT scan was done was normal , MRI showed optic nerve swelling ), 

ophtalmic exam done 16/10   showed bilateral papliedema , started on diamox.

- transfer to pediatric ICU with high blood pressure readings ( 140/100 ) on 

amlodipine 2.5mg q24h , hydralazine PRN , since transfer her blood pressure 

readings are within acceptable range ( 120/60-70 ) didnt recive any hydralazine 

doses 

- had persisntent tacycardia , septic workup and was started on tazocin and 

amikacin 

- TIT and bone marrow were done 17/10 ( CSF showed WBC of 1300 , opening presure

 

28 ) and CSF flowcytometry was consistent with B cell leukemia

- started on dexa 8mg/m2 17/10 

 

--------------------------------------------------------------------

oncology : 

 

 

- started on dexa 8mg/m2 17/10

 

 

- bone marrow relapse  ( periphral flowcytometry  8% disease )

- CNS relapse  ( CSF flowcytometry was consistentt with relapse 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

MRI : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

RESPIRATORY :

ON    room air       , O2 SAT ABOVE 97%

Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

 

 

CXR : normal 

 

 

 

 

-----------------------------------------------------------------------

CVS :

HR  130-140  BP 110-120/60-70 

NORMAL CAPILARY REFIL 

PALPABLE PERPHRAL PULSES 

 

 

LINE : periphral 

 

HYDRALAZINE 0.2mg/kg/dose q4h prn 

amlodipine 2.5 mg q24h 

 

ECHO (17/10):mild mitral valve prolapse with no MR (benign )

 

-----------------------------------------------------------------------

CNS :

CONSCIOUS , ALERT ORIENTED 

GCS : 15/15 

left eye exotropia + limitation on adduction 

 

ON :

paracetamol PRN 

GABAPENTIN  300MG ORAL BID 

levETIRAcetam   300MG   BID 

acetaZOLAMIDE TAB 250MG PO Q12H 

 

brain ct scan with contrast 15/10 : unremarkable 

brain MRI 17/10 : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

GI : 

SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

 

- low bacterial diet 

- nexium 

- IV fluid maintenance 

 

 

RENAL DOPPLER u/s 17/10 :

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

 

 

----------------------------------------------------------------------

HEME /ID :

afebrile 

 

ON :

tazocin day 3

amikacn day 3

 

blood culture 17/10 : pending 

stool culture 17/10 : pending 

 

 

 

 

----------------------------------------------------------------------

PLAN :

- observe blood pressure readings 

- check pending cultures 

- check official flowcytometry and bone marrow results 

- chek with primary team according to start chemotherapy

- transfere to the floor when available bed 

 

 

 

 




================================================================================
Date: 2024-10-19 06:39
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: AYAAD,FARH FARAJ HASAN
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     suspected relapsed ALL             

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     NA                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-18 20:00    FA                                            34.50 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     18/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     general                            

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     Throb                              

  2024-10-18 20:00    FA                     Sharp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     SUDDEN ONSET                       

  2024-10-18 20:00    FA                     Intermittent                       

  2024-10-18 20:00    FA                     OCCURS WITH MOVEMENT               

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     rest , medications                 

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     Paracetamol 500 mg                 

                                             ,Gabapentin 300 mg .               

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     PRN                                

  2024-10-18 20:00    FA                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     IV                                 

  2024-10-18 20:00    FA                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     to decrease level of pain          

                                             below (4/10).                      

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     0/10                               

  2024-10-19 00:00    FA                     0/10                               

  2024-10-19 04:00    FA                     0/10                               

  2024-10-19 06:00    FA                     0/10                               

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     GABAPENTIN 300 mg po               

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     0=Alert                            

  2024-10-19 00:00    FA                     S=Normal Sleep                     

  2024-10-19 04:00    FA                     0=Alert                            

  2024-10-19 06:00    FA                     S=Normal Sleep                     

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 20:00    FA                     NA                                 

  2024-10-19 00:00    FA                     NA                                 

  2024-10-19 04:00    FA                     NA                                 

  2024-10-19 06:00    FA                     NA                                 

 

 

 

 

 

 

 




================================================================================
Date: 2024-10-18 18:28
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: LAFI,BUSHRA RASHAD A.
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     ALL                                

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     NA                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-18 08:00    BL                                            34.50 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     17/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     back                               

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     Other                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     SUDDEN ONSET                       

  2024-10-18 08:00    BL                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     Movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     rest, medications                  

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     Paracetamol 500 mg,                

                                             Gabapentin 300 mg                  

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     Continuous                         

  2024-10-18 08:00    BL                     PRN                                

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     IV                                 

  2024-10-18 08:00    BL                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     To relief pain                     

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     0/10                               

  2024-10-18 12:00    BL                     0/10                               

  2024-10-18 16:00    BL                     0/10                               

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     Gabapentin 300 mg                  

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     0=Alert                            

  2024-10-18 12:00    BL                     0=Alert                            

  2024-10-18 16:00    BL                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-18 08:00    BL                     NA                                 

  2024-10-18 12:00    BL                     NA                                 

  2024-10-18 16:00    BL                     NA                                 

 

 

 




================================================================================
Date: 2024-10-18 09:36
Type: PHYSICIAN CRITICAL CARE NOTE
Author: MUHANNA,AYA MUHANNA ADEL
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
 

 

PEDIATRIC ICU ACCEPTANCE NOTE 

-----------------------------------------------------------------

 

PROBLEM LIST: 

IS A ********** year old female patient a case of low risk B cell ALL , off therapy 

12/2023 

- bone marrow relapse  ( periphral blood film  8% disease ) 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

 

 

ICU course : 

presented through emergency department with high blood pressure readings 15/10 ,

 

abnormal eye movements

- periphral flowcytometry showed 8% blasts. 

-admitted to pediatric floor for observation and managment of blood pressure 

readings , dr edward was consulted plan was to start her on amlodipine and 

hydralazine PRN 

- brain CT scan was done was normal , MRI showed optic nerve swelling ), 

ophtalmic exam done 16/10   showed bilateral papliedema , started on diamox.

- transfer to pediatric ICU with high blood pressure readings ( 140/100 ) on 

amlodipine 2.5mg q24h , hydralazine PRN , since transfer her blood pressure 

readings are within acceptable range ( 120/60-70 ) didnt recive any hydralazine 

doses 

- had persisntent tacycardia , septic workup and was started on tazocin and 

amikacin 

- TIT and bone marrow were done 17/10 ( CSF showed WBC of 1300 , opening presure

 

28 ) and CSF flowcytometry was consistent with B cell leukemia

- started on dexa 8mg/m2 17/10 

 

--------------------------------------------------------------------

oncology : 

 

 

- started on dexa 8mg/m2 17/10

 

 

- bone marrow relapse  ( periphral flowcytometry  8% disease )

- CNS relapse  ( CSF flowcytometry was consistentt with relapse 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

MRI : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

RESPIRATORY :

ON    room air       , O2 SAT ABOVE 95

Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

VBG: 

 

CXR : normal 

 

 

 

 

-----------------------------------------------------------------------

CVS :

HR  140 BP 145/100 

NORMAL CAPILARY REFIL 

PALPABLE PERPHRAL PULSES 

 

 

LINE : periphral 

 

HYDRALAZINE 0.2mg/kg/dose q4h prn 

amlodipine 2.5 mg q24h 

 

 

-----------------------------------------------------------------------

CNS :

CONSCIOUS , ALERT ORIENTED 

GCS : 15/15 

left eye exotropia + limitation on adduction 

 

ON :

paracetamol PRN 

GABAPENTIN  300MG ORAL BID 

levETIRAcetam   300MG   BID 

acetaZOLAMIDE TAB 250MG PO Q12H 

 

brain ct scan with contrast 15/10 : unremarkable 

brain MRI 17/10 : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

GI : 

SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

 

-low bacterial diet 

-nexium 

- IV fluid maintenance 

 

 

RENAL DOPPLER u/s 17/10 :

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

 

 

----------------------------------------------------------------------

HEME /ID :

afebrile 

 

ON :

tazocin day 2

amikacn day 2

 

blood culture 17/10 : pending 

stool culture 17/10 : pending 

 

 

 

 

----------------------------------------------------------------------

PLAN :

- observe blood pressure readings 

- check pending cultures 

- check official flowcytometry and bone marrow results 

 

 




================================================================================
Date: 2024-10-18 06:21
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: KHADER,FERYAL HASAN MAHMOUD
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     ALL                                

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     NA                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-17 20:00    ff                                            34.50 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     17/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     Back                               

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     Sharp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     SUDDEN ONSET                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     rest, analgesia                    

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     parcetamol (10mg=1ml)-500mg ,      

                                             gabatrex 300mg                     

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     PRN                                

  2024-10-17 20:00    ff                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     IV                                 

  2024-10-17 20:00    ff                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     pain more than 4/10                

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     0/10                               

  2024-10-17 23:00    ff                     6/10                               

  2024-10-18 00:00    ff                     0/10                               

  2024-10-18 04:00    ff                     0/10                               

  2024-10-18 06:00    ff                     0/10                               

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 23:30    ff                     0/10                               

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 23:00    ff                     parectamol 500mg iv                

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 23:00    ff                     50ml                               

                                                            ------------        

                                                  Minimum:          0.00        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     gabatrex 300mg po                  

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     0=Alert                            

  2024-10-18 00:00    ff                     0=Alert                            

  2024-10-18 04:00    ff                     0=Alert                            

  2024-10-18 06:00    ff                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 20:00    ff                     NA                                 

  2024-10-18 00:00    ff                     NA                                 

  2024-10-18 04:00    ff                     NA                                 

  2024-10-18 06:00    ff                     NA                                 

 

 

 

 

 

 

 




================================================================================
Date: 2024-10-17 18:47
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: LAFI,BUSHRA RASHAD A.
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 07:48    MF                     ALL                                

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     NA                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-17 07:48    MF                                            34.50 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 07:51    MF                     16/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     Headache                           

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     Throb                              

  2024-10-17 08:00    MF                     Sharp                              

  2024-10-17 08:00    MF                     Pressure                           

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     Movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     Analgesic                          

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     PARACETAMOL 10MG/ML 500 MG IV      

                                             Q6H PRN 15mg/kg fever or pain      

                                             , GABAPENTIN CAP,ORAL 300MG        

                                             PO BID                             

  2024-10-17 11:45    MF                     morphine 2 IV mg once stat         

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     PRN                                

  2024-10-17 08:00    MF                     Regular                            

  2024-10-17 11:45    MF                     STAT                               

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     IV                                 

  2024-10-17 08:00    MF                     PO -Oral intake                    

  2024-10-17 11:45    MF                     IV                                 

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     PARACETAMOL 10MG/ML 500 MG IV      

                                             Q6H PRN 15mg/kg fever or pain      

                                             , GABAPENTIN CAP,ORAL 300MG        

                                             PO BID                             

  2024-10-17 11:45    MF                     morphine 2 IV mg once stat         

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     0                                  

  2024-10-17 11:30    MF                     8                                  

  2024-10-17 12:00    BL                     0/10                               

  2024-10-17 16:00    BL                     0/10                               

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 12:00    BL                     0/10                               

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 11:45    MF                     Morphine 2 mg IV                   

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     GABAPENTIN CAP,ORAL 300MG PO       

                                             BID                                

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     0=Alert                            

  2024-10-17 12:00    BL                     0=Alert                            

  2024-10-17 16:00    BL                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     NA                                 

  2024-10-17 12:00    BL                     NA                                 

  2024-10-17 16:00    BL                     NA                                 

 

 

 

 

 

 

 

 

 




================================================================================
Date: 2024-10-17 17:00
Type: CONSULT NOTE
Author: HASHEM,FARAH MOTAZ FEKRY
Location: KHCC-6H-PEDIATRIC
Service: SOCIAL WORK
================================================================================

'
Patient was seen for a mental state assessment in response to consult. 

Accompanied by grandfather. She has 2 brothers and 2 sisters; she is the eldest.

 

During the session, she was conscious, oriented, responsive, but drowsy. She was

 

cooperative and engaged in guided discussion. Sad, easily irritable, low affect.

 

Patient reported constant pain in her head and neck. Fatigue, lethargy, proper 

appetite, disturbed sleep due to pain. Patient attends school inconsistently due

 

to her medical condition. Grandfather reported that the patient was doing well 

up until 3 months ago when she started vommitting. About a month ago, she 

started experiencing constant headaches, high blood pressure, inability to walk,

 

weakened physical abilities, and constant heat in her hands. Patient reported 

she feels sad, distressed, and angry because she is unable to play with her 

siblings and cousins like before. She also reported she washes her hands several

 

times with cold water hoping for the heat in her palms to go away (not OCD).

Provided active listening, emotional validation and support, and reassurance to 

patient. Provided family support to grandfather.

 

Impression: Needs further assessment once medical reasons are ruled out.

 

To be followed for further assessment and support as needed.

 

Refer to pediatric psychologist note for full mental state assessment.




================================================================================
Date: 2024-10-17 15:23
Type: LR CYTOPATHOLOGY REPORT
Author: BARAKAT,FAREED HANI FAREED
Location: KHCC-6H-PEDIATRIC
Service: LABORATORY
================================================================================

'
$APHDR

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Laboratory: KING HUSSEIN CANCER CENTER

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

 

Diagnosis :

     CLINICAL HISTORY: 

      A case of B-ALL.  

      

      

     SPECIMEN TYPE: 

      CSF.  

      

      

     GROSS DESCRIPTION: 

      Fluids: CSF. 

      Volume: 1.0ml. 

      Appearances: Clear. 

      Color: Colorless. 

      Tissue/Clot: Absent.  

      Total Number of Slides: 

      Air dried: 1.  

       

      

     FINAL DIAGNOSIS: 

      

     CSF, CYTOLOGY: 

      Many blasts seen.  

      

      

      

      

     ********** ********** **********t, M.D. **********SCP.  

 

/**********/ **********ED BARAKAT MD

 

Signed OCT 17, 2024@15:23:57




================================================================================
Date: 2024-10-17 15:12
Type: PEDIATRIC PSYCHOLOGIST NOTE
Author: HASHEM,FARAH MOTAZ FEKRY
Location: KHCC-6H-PEDIATRIC
Service: SOCIAL WORK
================================================================================

'
patient Name & Address:ZAHER-AL-SHAM AHMAD AWAD ALSHEBLI

**********

**********

**********,     patient ID:**********

patient age:**********yr **********mo    patient DOP:**********

patient sex:FEMALE

Date:Oct 17,2024

--------------------------------------------------------------------------------

                      MENTAL STATE ASSESSMENT (PEDIATRIC)

--------------------------------------------------------------------------------

Allergy:ALLERGIES/ADVERSE REACTIONS - NONE FOUND

 

--------------------------------------------------------------------------------

Active problem:

Active problems - Computerized Problem List is the source for the following:

 

 1. Leukemia, Lymphocytic

 2. Syrian refugee

 3. sever vomiting after anesthesia 

 4. delayed MTX excretion

 5. Pancytopenia

 6. septic shock ICU admission 

 7. TBNK flow: low

 8. chemosensitivity for workup

 9. Suspected relapse

10. Papilledema 

============================= REASON FOR REFERRAL==============================

BEHAVIORAL , COGNITIVE

=================================FAMILY HISTORY================================

SIZE OF THE FAMILY:

Small(less than 6 children)

 

ECONOMIC STATUS AND RESOURCES:

Good financial status 

 

THE STRUCTURE OF THE FAMILY PARENT SOCIAL STATUS:

living together

 

HISTORY OF MENTAL ILLNESS:

Not reported

================================EDUCATION HISTORY==============================

GRADE AND SCHOOL PERFORMANCE:

Strongly affected 

 

RELATIONSHIP WITH PEERS:

Strongly affected 

 

RELATIONSHIP WITH TEACHERS:

Affected 

 

GENERAL FUNCTIONING CONDITIONS:

Strongly affected 

================================= ASSESSMENT===================================

Apperance & Attitude:

Cooperative , Responsive , Drowsy

 

SENSORY:

Conscious , concentration, Orientation to Time,Place,Person

 

MOOD AND AFFECT:

Sad, Irritable

 

SLEEP:

Not good (due to pain)

 

APPETITE:

Good

 

SPEECH:

Pressured

 

THINKING:

Proper

 

COGNITIVE FUNCTION:

Needs further assessment

 

PERCEPTION:

Proper

 

JUDGMENT:

Proper

 

=================================IMPRESSION====================================

Needs further assessment. 

===============================INTERVENTION PLAN===============================

Patient was seen for a mental state assessment in response to consult. 

Accompanied by grandfather. She has 2 brothers and 2 sisters; she is the eldest.

 

During the session, she was conscious, oriented, responsive, but drowsy. She was

 

cooperative and engaged in guided discussion. Sad, easily irritable, low affect.

 

Patient reported constant pain in her head and neck. Fatigue, lethargy, proper 

appetite, disturbed sleep due to pain. Patient attends school inconsistently due

 

to her medical condition. Grandfather reported that the patient was doing well 

up until 3 months ago when she started vommitting. About a month ago, she 

started experiencing constant headaches, high blood pressure, inability to walk,

 

weakened physical abilities, and constant heat in her hands. Patient reported 

she feels sad, distressed, and angry because she is unable to play with her 

siblings and cousins like before. She also reported she washes her hands several

 

times with cold water hoping for the heat in her palms to go away (not OCD).

Provided active listening, emotional validation and support, and reassurance to 

patient. Provided family support to grandfather. 

 

To be followed for further assessment and support as needed.

 




================================================================================
Date: 2024-10-17 14:44
Type: SOCIAL WORKER PROGRESS NOTES
Author: ALWARAYDAT,TAMARA ADEL NADI
Location: KHCC-6H-PEDIATRIC
Service: SOCIAL WORK
================================================================================

'
The patient was not in the room; she had just been transferred to P.ICU, to be 

followed up later




================================================================================
Date: 2024-10-17 14:44
Type: PEDIATRIC PHYSICIAN PROGRESS NOTE
Author: HASAN,LANA AMER FATEHI
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
 

 

                             PICU TRANSFER NOTE:

                             ===================

 

 

Zaher **********-**********ham is an ********** Year old girl a case of low risk B cell ALL

 

status post: off therpay on 12/12/2023

 

Admitted yesterday as case of relapse B-ALL confirmed by flow cytometry

 

 

15/10 ER:

=========

referred from clinic to ER to manage blood pressure and pain,consult Nephrology,

 

do Urgent CT Brain 

 

Before 1 month, she started compalining of back pain then became diffuse bony 

pain 

also complaining of on/off headache, polyuria and polydepsia

in last 2 weeks, she satrted complaining of unsteady gait and abnormal behavior 

(she washed her hands many times as she feel hotness)

 

there was ataxia and diminished knee relfex

there was slugish left pupil

 

-CBC: Hgb 13.3/ wbc 6.6/ ANC 2400 / chem: UNREMARKBLE / glucocheck: 178

-did brain CT with contrast: unremarkble

-sent urine analysis and culture: URINE PROTEIN  +1 URINE BLOOD/HB  +3 

-sent blood film: pending

-nephrology consult:

Dr.**********f infomred Dr.********** by phone and the plan to: record the measurment of 

blood pressure in the next 2 days and to return to clinic after 2 days

no need to start antihypertensive medication as this time, blood pressure 

reading at upper limit

-pain consult: examined her next day and started her on gabapetin 300mg bid

 

During ER, her blood pressure reach to 145/100 so recived hydralazine 6mg

blood pressure before dishcrage: 126/94

 

 

16/10 ER:

=========

-repeaseanetd to ER

there was slugish left pupil, limitation in eye movement , multidirectional 

nystagmus , wide based gait , ataxic 

 

-Opthalmology consulted -> 

left eye exotropia + limitation on adduction 

papilledema- treat her increased ICP- Brain + Orbit Mri to rule out brain vs 

orbital leukemic infiltrtaion is needed

diamox dose + steroid is recommended to decrease intracranial pressure till you 

resolve the underlying cause

 

-Nephrology consulted ->start on amlodipine 2.5mg Qday 

Renal U/S tomorrow 

 

-RECEIVED PERFALGAN, HYDRLAZINE, AND DEXA 4 mg

 

-blood film:

 RBC's: normocytic, normochromic with ploychromasia 

  and occasional NRBCs. 

 WBC's: normal total count with mild lymphocytosis and 

 rare blasts seen. 

 Platelets: thrombocytopenia. 

 

-flow cytometry: 8% blast 

 

 

16/10 FLOOR:

============

-admitted to floor as case of relapsed B-ALL confirmed by flow cytometry for 

workup and rule in CNS relapse

 

-admitted on keppra 300 mg bid, diamox 250mg bid , amlodipine 2.5mg Qday

 

-underwenr MRI BRAIN WITH CONTRAST :

There is mild optic nerve sheath distension measuring about 7mm on the left 

suggesting increased intracranial hypertension.

 

-Neurosurgury consult before Lumbar puncture:

No Contraindications to Do LP.

 

 

Today:

======

 

Infectious wise:

-afebrile, off antibiotics

 

Hematology wise:

-Hgb 14/ wbc 9/ ANC 3000

 

Chemsirty wise:

-ALT/AST 167/152 (trending up)

 

Nephrology wise:

-last night she recived 2 hydralazine for high blood pressure reading

-Today at 9am her blood pressure was 148/103, recived hydralazine and at 11am 

was 145/105. persinstant hypertense regardless hydralazine. 

-renal ultrasound:

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

""so transferred to PICU to manage high blood pressure reading""

 

Pain wise:

-at 11am recived perflegan and morphine stat due to headache and anxiious

 

Oncology wise:

-will do bone marrow and triple intrathecal in PICU

 

Respiratory wise:

-there is mild cough, clear chest

 

Neurology assesmsnet:

-there is slugish left pupil, limitation in eye movement , multidirectional 

nystagmus , wide based gait , ataxic 

-there is mild headache and lower limb pain

 

 

plan:

-will transfer to PICU to manage blood pressure

-will do ECHO, chest xray

-send respiratory panel

-Daily CBC and chemistry.

 




================================================================================
Date: 2024-10-17 13:36
Type: PHYSICIAN PALLIATIVE PROGRESS NOTES
Author: BANI MUSTAFA,AMAL MUSTAFA AHMAD
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
patient Name:**********  patient ID:**********

patient Age:8yr **********mo    patient DOB:**********

patient Sex:FEMALE    Date: OCT 17, 2024

ATTENDING PHYSICIAN:ATTENDING PHYSICIAN - AL-HMOOD**********AMMAR YAHYA AHMAD

--------------------------------------------------------------------------------

                     PALLIATIVE PHYSICIAN PROGRESS NOTE

--------------------------------------------------------------------------------

-----------------------------Initial Assessment---------------------------------

Vital Sings:

RESPIRATION:    22 (10/17/2024 11:40)

BLOOD PRESSURE: 135/94 (10/17/2024 11:13)

PULSE:          150 (10/17/2024 11:40)

PULSE OXIMETRY: 10/17/24 @ 1140     PULSE OXIMETRY: 98

TEMPERATURE:    98.2 F [36.8 C] (10/17/2024 11:40)

WEIGHT:         76.06 lb [34.6 kg] (10/16/2024 18:10)

Height:         52.756 in [134.0 cm] (10/16/2024 18:10)

LBM:            Oct 17,2024

--------------------------------------------------------------------------------

Allergy:Patient has answered NKA

--------------------------------------------------------------------------------

Problems:

Active problems - Computerized Problem List is the source for the following:

 

 1. Leukemia, Lymphocytic                             02/06/22  MSAMEH,ALAA YOUS

 2. Syrian refugee                                    02/06/22  ZANDAKI,DUAA AHM

 3. sever vomiting after anesthesia                   05/25/21  ALSHATHLY,MUHANA

 4. delayed MTX excretion                             05/25/21  ALSHATHLY,MUHANA

 5. Pancytopenia                                      02/06/22  HAJJIR,HALA AHMA

 6. septic shock ICU admission                        11/14/21  GUZU,TASNEEM ALI

 7. TBNK flow: low                                    02/06/22  BUDAIR,RAWAN NOU

 8. chemosensitivity for workup                       04/03/22  ZANDAKI,DUAA AHM

 9. Suspected relapse                                 10/17/24  MUQBEL,ROA ABDUL

10. Papilledema                                       10/17/24  MUQBEL,ROA ABDUL

--------------------------------------------------------------------------------

Zaher is ********** years old , known case of B-ALL.

-S/P: off therapy since 12/23

-cause of consult : bilateral wrist pain and hotness

                    she started to have headache ,sever in nature 

-duration : 2weeks 

-pain socre4/10

-neuropathy in her bilateral hands 

 

 

 

ZAHER ALSHAM transfered to ER due to sever headache ,WE HAVE PHONED HER 

GRANDFATHER BY PHONE 

she has new onset of unsteady gait and hotness of bilateral hands 

>>was given 2mg IV morphine .

 

medications:

-------------

-gabapentin 300mg po bid .

 

 

plan:

----

need further evlaution for headache .

follow pain 

observe hypertension 

 




================================================================================
Date: 2024-10-17 13:12
Type: CONSULT NOTE
Author: SALAYMEH,KHALED JAMAL SADEQ
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICIAN
================================================================================

'
8 YEARS 9 MONTHS

 

-Patient Diagnosis: B CELL ALL

-Type of Chemotherapy:-

-Chemotherapy Start Date:-

-Chemotherapy End Date:-

- If anthracylines given , accumulative dose:80MG/M2

If the Patient Takes anthracylines, put accumulation dose 80MG/M2

Reason for Consult:FOR EVALUATION

 

O/E:

 

head and neck: normal

chest: CTA

heart: normal S1 w normal S2 w no murmur

abdomen: soft

normal femoral pulses

 

echo:

1) Structurally normal heart WITH MILD MITRAL VALVE PROLAPSE WITH NO MR

2) Nomal LA and LV size w normal systolic function (LVEF 65%)

3) NORMAL MITRAL VALVE INFLOW INDICATING NORMAL LV RELAXATION

4) Normal left sided aortic arch

5) Normal pulmonary and systemic venous return

 

A/P MILD MITRAL VALVE PROLAPSE WITH NO MR, BENIGN

NORMAL LV SIZE AND SYSTOLIC FUNCTION, LVEF 65%

FU IN 1 YEAR, OCT 2025

 




================================================================================
Date: 2024-10-17 12:40
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: FARRAYEH,MUNA AWAD IBRAHIM
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 07:48    MF                     ALL                                

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     NA                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-17 07:48    MF                                            34.50 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 07:51    MF                     16/10/2024                         

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     Headache                           

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     Throb                              

  2024-10-17 08:00    MF                     Sharp                              

  2024-10-17 08:00    MF                     Pressure                           

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     Movement                           

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     Analgesic                          

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     PARACETAMOL 10MG/ML 500 MG IV      

                                             Q6H PRN 15mg/kg fever or pain      

                                             , GABAPENTIN CAP,ORAL 300MG        

                                             PO BID                             

  2024-10-17 11:45    MF                     morphine 2 IV mg once stat         

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     PRN                                

  2024-10-17 08:00    MF                     Regular                            

  2024-10-17 11:45    MF                     STAT                               

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     IV                                 

  2024-10-17 08:00    MF                     PO -Oral intake                    

  2024-10-17 11:45    MF                     IV                                 

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     PARACETAMOL 10MG/ML 500 MG IV      

                                             Q6H PRN 15mg/kg fever or pain      

                                             , GABAPENTIN CAP,ORAL 300MG        

                                             PO BID                             

  2024-10-17 11:45    MF                     morphine 2 IV mg once stat         

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     0                                  

  2024-10-17 11:30    MF                     8                                  

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 11:45    MF                     Morphine 2 mg IV                   

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     GABAPENTIN CAP,ORAL 300MG PO       

                                             BID                                

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-17 08:00    MF                     NA                                 

 

 

 

 

 

 




================================================================================
Date: 2024-10-17 11:29
Type: PHYSICIAN CRITICAL CARE NOTE
Author: MUHANNA,AYA MUHANNA ADEL
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
 

 

PEDIATRIC ICU ACCEPTANCE NOTE 

-----------------------------------------------------------------

 

PROBLEM LIST: 

IS A ********** year old female patient a case of low risk B cell ALL , off therapy 

12/2023 

- bone marrow relapse  ( periphral blood film  8% disease ) 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

presented through emergency department with high blood pressure readings 15/10 ,

 

abnormal eye movements ( brain CT scan was done was normal , MRI showed optic 

nerve swelling )

ophtalmic exam done 16/10   showed bilateral papliedema 

admitted to pediatric floor for observation and managment of blood pressure 

readings 

dr edward was consulted plan was to start her on amlodipine and hydralazine PRN 

todays readings 140-145/90-100

TRANSFERRED TO PICU for observation and managment of blood pressure readings 

 

 

--------------------------------------------------------------------

oncology : 

 

- bone marrow relapse  ( periphral blood film  8% disease ) 

- left eye exotropia + limitation on adduction  , bilateral papilledma 

ICU admission : high blood pressure readings for managment and observation 

 

 

MRI : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

RESPIRATORY :

ON    room air       , O2 SAT ABOVE 95

Good Bilateral  Air Entry  NO ADDED SOUNDS 

 

 

VBG:not done 

 

CXR : normal 

 

 

 

 

-----------------------------------------------------------------------

CVS :

HR  140 BP 145/100 

NORMAL CAPILARY REFIL 

PALPABLE PERPHRAL PULSES 

 

 

LINE : periphral 

 

HYDRALAZINE 0.2mg/kg/dose q4h prn 

amlodipine 2.5 mg q24h 

 

 

-----------------------------------------------------------------------

CNS :

CONSCIOUS , ALERT ORIENTED 

GCS : 15/15 

left eye exotropia + limitation on adduction 

 

ON :

paracetamol PRN 

GABAPENTIN  300MG ORAL BID 

levETIRAcetam   300MG   BID 

 acetaZOLAMIDE TAB 250MG PO Q12H 

 

brain ct scan with contrast 15/10 : unremarkable 

brain MRI 17/10 : optic nerve swelling 

 

 

-----------------------------------------------------------------------

 

GI : 

SOFT LAX ABDOMEN , HEPATOSPLENIMEGALY 

 

 

-NPO 

 

RENAL DOPPLER u/s 17/10 :

       Hepatosplenomegaly with liver span 14 cm and spleen span 14.6 cm. 

Unremarkable normal renal Doppler scan, no signs of renal artery stenosis.

 

 

 

----------------------------------------------------------------------

HEME /ID :

AFEBRILE 

 

ON :

off antibiotics 

 

 

 

----------------------------------------------------------------------

PLAN :

- transfer to pediatric ICU 

- observe blood pressure readings 

- Bone marrow and TIT 




================================================================================
Date: 2024-10-17 08:29
Type: Nutrition Pediatric  Assessment
Author: AL-NAJDAWI,ELHAM AHMAD MAHMOUD
Location: KHCC-6H-PEDIATRIC
Service: NUTRITION
================================================================================

'
--------------------------------------------------------------------------------

                        Pediatric Nutrition Assessment Note

--------------------------------------------------------------------------------

Allergy:ALLERGIES/ADVERSE REACTIONS - NONE FOUND

--------------------------------------------------------------------------------

Problems:

Active problems - Computerized Problem List is the source for the following:

 

 1. Leukemia, Lymphocytic                             02/06/22  MSAMEH,ALAA **********S

 2. Syrian refugee                                    02/06/22  ZANDAKI,DUAA AHM

 3. sever vomiting after anesthesia                   05/25/21  ALSHATHLY,MUHANA

 4. delayed MTX excretion                             05/25/21  ALSHATHLY,MUHANA

 5. Pancytopenia                                      02/06/22  HAJJIR,HALA AHMA

 6. septic shock ICU admission                        11/14/21  GUZU,TASNEEM ALI

 7. TBNK flow: low                                    02/06/22  BUDAIR,RAWAN NOU

 8. chemosensitivity for workup                       04/03/22  ZANDAKI,DUAA AHM

 9. Suspected relapse                                 10/17/24  MUQBEL,ROA ABDUL

10. Papilledema                                       10/17/24  MUQBEL,ROA ABDUL

--------------------------------------------------------------------------------

Diagnosis:  case of B cell ALL

 

--------------------------------------------------------------------------------

Reason of Admission :suspected relapse

--------------------------------------------------------------------------------

Current treatment modality::  - status post: off therapy on 12/12/2023

--------------------------------------------------------------------------------

Oral Intake:Adequate (more than 60% of the total caloric requirements)

--------------------------------------------------------------------------------

Current Weight:34.5Kg Height:134cm.BMI: 19.2

BMI/Age:********** 

The Patient is:Over Weight

Previous documented weight

10/16/24 @ 1810     WEIGHT: 76.06 lb. ( 34.57 kg.)

Ideal Body weight:29Kg

Weight /ideal body weight:119%

Weight /age:84%   height/age: 65% 

Total daily caloric requirement: 1800kcal/d.

Total daily Protein requirement: 72g/d

 

-----------------------------Investigation--------------------------------------

 

Lipid profile:LIPID PROFILE Coll. datCHOL    TRIG    HDL     LDL

1/16/24 10:47                      123.00  70.60   47.70   61 

 

  Collection time:          Oct 17, 2024@00:07:29

   Test Name                 Result    Units           Range

 

ALBUMIN                       4.4      g/dL        3.6 - 5.3

 

 

-------------------------------------Assessment---------------------------------

Nutritional status:

.adequate oral intake 

.normal albumin level 

.patient today npo 

. weight gain 12  kg last 1 year ago 

.patient is over weight 

.normal lipid profil 

 

---------------------------Nutritional Plan of care-----------------------------

patient father was educated about well balanced diet 

when diet resume give patient well balanced diet , avoid fat by food and sweet 

 rtc in nutrition clinic




================================================================================
Date: 2024-10-17 07:24
Type: MEDICATION RECONCILIATION NOTE
Author: HASSOUNEH,DANA ABDULLAH AHMED
Location: KHCC-6H-PEDIATRIC
Service: PHARMACY
================================================================================

'
========================== Medication Reconciliation ==================== 

Allergies: Patient has answered NKA

=============================== Admission ============================ 

SOURCE OF MEDICATION:Patient/Family Reach, Previous Discharge Order

 

Home Medication list: 

 

GABAPENTIN 300MG CAP                      Fill Date: OCT 2,2024

Sig: TAKE ONE CAPSULE BY MOUTH EVERY 12 HOURS TAKE WITH OR WITHOUT FOOD. 

     TAKE WITH FOOD IF IT CAUSES AN UPSET STOMACH.

==ORDERED

 

LANSOPRAZOLE 15MG CAP                     Fill Date: SEP 22,2024

Sig: TAKE ONE CAPSULE BY MOUTH EVERY DAY ADMINISTER ONE HOUR BEFORE 

     BREAKFAST.

==ORDERD AS ESOMEPRAZOLE IV

 

MERCAPTOPURINE 50MG TAB                   Fill Date: NOV 7,2023

Sig: TAKE ONE TABLET BY MOUTH EVERY DAY FOR 6 DAYS TAKE AT THE SAME TIME OF 

     THE DAY. MAINTAIN ADEQUATE HYDRATION. DO NOT CRUSH OR CHEW 

     CHEMOTHERAPY. 6MP 50MG/M2/DAY = 6TABS/WEEK 6MP 50MG/M2/DAY = 

     6TABS/WEEK 6MP 50MG/M2/DAY = 6TABS/WEEK  6MP 50MG/M2/DAY = 6TABS/WEEK 

     6MP 50MG/M2/DAY = 6TABS/WEEK  6MP 50MG/M2/DAY = 6TABS/WEEK

==off treatment 

 

METHOTREXATE 2.5MG TAB                    Fill Date: NOV 7,2023

Sig: TAKE 16M BY MOUTH EVERY 1 WEEK TAKE ON AN EMPTY STOMACH. TAKE 1 HOUR 

     BEFORE OR 2 HOURS AFTER MEALS.SWALLOW TABLETS WHOLE;DO NOT SPLIT, 

     CRUSH, OR CHEW.CHEMOTHERAPY. 20MG/M2/WEEK 20MG/M2/WEEK 20MG/M2/WEEK 

     20MG/M2/WEEK 20 MG / M2 20 MG / M2 20 MG / M2 15 MG/M2 20 MG/M2 = 6 

     TABS WEEKLY 20 MG / M2 = 6 TABS WEEKLY 20 MG / M2 = 6 TABS WEEKLY  20 

     MG / M2 = 6 TABS WEEKLY

==off treatment 

 

ONDANSETRON 8MG TAB                       Fill Date: SEP 20,2024

Sig: TAKE 4MGG BY MOUTH EVERY 8 HOURS PRN TAKE WITHOUT REGARD TO MEALS. 

     0.15 MG/KG FOR VOMTING

==not indicated, will be ordered if needed

 

VITAMIN D3 50000 TAB                      Fill Date: JAN 16,2024

Sig: TAKE 1 TABLET BY MOUTH EVERY 1 WEEK FOR 8 WEEKS, THEN TAKE 1 TABLET 

     EVERY MONTH TAKE THIS DRUG WITH FOOD AT THE SAME TIME OF DAY.

==not ordered, to be resumed when possible 




================================================================================
Date: 2024-10-17 07:24
Type: CLINICAL PHARMACIST NOTE
Author: HASSOUNEH,DANA ABDULLAH AHMED
Location: KHCC-6H-PEDIATRIC
Service: PHARMACY
================================================================================

'
PATIENT WEIGHT: 76.06 lb [34.6 kg] (10/16/2024 18:10)

PATIENT HEIGHT: 52.756 in [134.0 cm] (10/16/2024 18:10)

ALLERGIES : ALLERGIES/ADVERSE REACTIONS - NONE FOUND

 

 

Active Inpatient Medications (including Supplies):

 

     Active Inpatient Medications                           Status

=========================================================================

1)   GABAPENTIN CAP,ORAL  300MG PO BID                      ACTIVE

2)   NYSTATIN SUSP,ORAL  100000UNIT/1ML PO TID SWISH AND    ACTIVE

       SWALLOW

3)   PARACETAMOL INJ  500 MG IV Q6H PRN 15mg/kg fever or    ACTIVE

       pain

4)   POVIDONE IODINE SOLN,TOP  AS DIRECTED POVIDONE IODINE  ACTIVE

       10% SOLN 120ML TOP TID

5)   SODIUM BICARBONATE MOUTHWASH  5 ML PO TID SWISH AND    ACTIVE

       SPLIT

6)   ZINC OXIDE PASTE  A SAMLL AMOUNT TOP TID ON PERIANAL   ACTIVE

       AREA

7)   acetaZOLAMIDE TAB  250MG PO BID 15mg/kg                ACTIVE

8)   amLODIPine TAB  2.5 MG PO BID as per nephro plan       ACTIVE

9)   hydrALAZINE INJ,SOLN hydrALAZINE 6 MG in NORMAL        ACTIVE

       SALINE SYRINGE 0.3 ML  INFUSE OVER 20 MINUTES

       0.2mg/kg IV Q4H PRN

10)  levETIRAcetam SOLN  300MG PO BID ppx 20mg/kg/day       ACTIVE

 

 

**********aher Al**********ham is an **********-year-old ********** girl, diagnosed with low risk B cell 

ALL, has been off therapy since Decemeber 2023. 

 

She has only recently presented to the clinic complaining of headache, polyuria,

 

and polydepsia (2 days ago). Yesterday, she presented to the ER with worsening 

headache, photophobia, nystagmus,and was hypertensive. Received hydralazine and 

was started on amlodipine. She also had an elevated intracranial pressure for 

which she was started on acetazolamide and cortcosteroids. Prophylactic 

levetiracetam was also started. 

 

Planned for orbit and brain MRI to rule out leukemic infiltration. Planned for 

bone marrow biopsy and triple intrathecal therapy if cleared by neuro. 

 

She was admitted to the floor for further observation and management.

 

Active issues:

--------------

1) Hypertension:

- readings above 140s/90s and complains of headache 

- started on amlodipine and hydralazine 

- elevated intracranial pressure

- on acetazolamide and received a single dose of dexamethasone 

- opthalmic exam showed bilateral papilledema

 

 

2)Disease status: 

- planned for triple intrathecal therapy today

- planned for bone marrow biopsy 

- bone marrow relapse( periphral blood film  8% disease ) 

 

** Please note that the patient later on was planned to be transferred to the 

ICU for elevated blood pressure readings and to receive triple intrathecal 

therapy.** 

 

Medications were reviewed

 

Recommendations:

 

1) To resume dexamethasone as planned. 




================================================================================
Date: 2024-10-17 06:51
Type: PHYSICIAN DIAGNOSTIC RADIOLOGY NOTE
Author: EL-SADI,JASMINE NASER ABDELFATTAH
Location: KHCC-6H-PEDIATRIC
Service: RADIOLOGY
================================================================================

'
This is a preliminary report for brain mri dated 16th oct 2024, please make sure

 

to check the official report once available:

 

Addendum:

There is mild optic nerve sheath distension measuring about 7mm on the left 

suggesting increased intracranial hypertension.

 

Dr **********a was informed at 6:45am.




================================================================================
Date: 2024-10-17 06:35
Type: PHYSICIAN SURGERY PROGRESS NOTES
Author: MASSADI,MUSTAFA SABRI MUHIEDDIN
Location: KHCC-6H-PEDIATRIC
Service: INTERNAL MEDICINE
================================================================================

'
 

===============

Follow up note:

===============

 

MRI Reviewed by Dr **********m.

No Contraindications to Do LP.




================================================================================
Date: 2024-10-17 06:24
Type: PAIN ASSESSMENT AND MANAGEMENT FLOWSHEET
Author: SHAMLLAWY,DANA WALEED ADEL
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
 

--------------------------------------------------------------------------------

                              General Information

--------------------------------------------------------------------------------

[Primary Diagnosis]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 21:39    HA                     ALL                                

 

[Operation]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     NA                                 

 

[Weight]

  Observed Date/Time  Initial Qualifiers                           Value

  2024-10-16 21:39    HA                                            34.50 (kg)  

 

[L.B.M]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Location Of Pain]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     HEADCHE                            

 

[Pain Rating Scale Used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     .NRS                               

 

[Pain Quality]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     Throb                              

  2024-10-16 20:00    DS                     Sharp                              

 

[Pattern]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     Intermittent                       

 

[Aggrevating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     disease process                    

 

[Alleviating Factors]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     analgesia and rest                 

 

[Analgesic Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     parecatmol 10mg/ml,                

                                             gabepentin 300mg                   

 

[Analgesic Prescribed]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     PRN                                

  2024-10-16 20:00    DS                     Regular                            

 

[Analgesia Route]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     IV                                 

  2024-10-16 20:00    DS                     PO -Oral intake                    

 

[Analgesia used]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     parecatmol 500mgl, gabepentin      

                                             300mg                              

 

 

--------------------------------------------------------------------------------

                                Pain Assessment

--------------------------------------------------------------------------------

[Pain Score Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     0                                  

  2024-10-17 00:00    DS                     0                                  

  2024-10-17 04:00    DS                     0                                  

 

[Pain Score Reassessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  IV Analgesic

--------------------------------------------------------------------------------

[I.V 1 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Average:           ***        

 

[I.V Regular Infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/one-time Medication "Dose and route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 1  Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 1 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

                                                            ------------        

                                                  Minimum:           ***        

 

 

--------------------------------------------------------------------------------

                                IV 2  Analgesic

--------------------------------------------------------------------------------

[I.V 2Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 2"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 2 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V.2 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 3  Analgesic

--------------------------------------------------------------------------------

[I.V 3 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 3"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V  3 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 3Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                IV 4  Analgesic

--------------------------------------------------------------------------------

[I.V 4 Continuous infusion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V Regular Infusion 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[PRN/One-Time Medication 4"Dose and Route"]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V 4 Stat Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[I.V. 4 Total amount given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                      PCA

--------------------------------------------------------------------------------

[PCA Analgesic Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[RATE OF INFUSION]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Reservoir Volume]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Demand Dose]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Maximum Dose/Hour]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Dose Attempted]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Time Interval]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Clinical Bolus]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Total PCA amount Given]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                    Epidural

--------------------------------------------------------------------------------

[Analgesia Name and Concentration]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Insertion Site Assessment]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Site of Insertion]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Epidural Infusion Rate ml/hr]

  Observed Date/Time  Initial Qualifiers                           Value

 

[Level Of Block (left)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Level Of Block (LRight)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score LT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Bromage Score RT]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                 Oral Analgesia

--------------------------------------------------------------------------------

[Oral Analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 21:04    DS                     gabepentin 300mg                   

  2024-10-17 04:23    DS                     gabpentin 300mg                    

 

[Oral Analgesia 2]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 3]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Oral Analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                             Transdermal Analgesia

--------------------------------------------------------------------------------

[Transdermal analgesia 1]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 2 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal 3 analgesia]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Transdermal analgesia 4]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                               Other analgesic(s)

--------------------------------------------------------------------------------

[Other Analgesic(s)]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                                  Nerve Block

--------------------------------------------------------------------------------

[Nerve Block]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Drug Name]

  Observed Date/Time  Initial Qualifiers     Value                      

 

[Infusion ml/hr]

  Observed Date/Time  Initial Qualifiers     Value                      

 

 

--------------------------------------------------------------------------------

                              Analgesic Assessment

--------------------------------------------------------------------------------

[Sedation Level]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     0=Alert                            

  2024-10-17 00:00    DS                     0=Alert                            

  2024-10-17 04:00    DS                     0=Alert                            

 

[Side Effects]

  Observed Date/Time  Initial Qualifiers     Value                      

  2024-10-16 20:00    DS                     NA                                 

  2024-10-17 00:00    DS                     NA                                 

  2024-10-17 04:00    DS                     NA                                 

 

 




================================================================================
Date: 2024-10-17 03:07
Type: PHYSICIAN DIAGNOSTIC RADIOLOGY NOTE
Author: EL-SADI,JASMINE NASER ABDELFATTAH
Location: KHCC-6H-PEDIATRIC
Service: RADIOLOGY
================================================================================

'
This is a preliminary report for brain mri dated 16th oct 2024, please make sure

 

to check the official report once available:

 

 

brain mri with conrtast:

Findings:

No acute infarction.

No active hydrocephalus.

No definite focal enhancing lesions.

 

Dr **********a was informed at 23:20 pm.




================================================================================
Date: 2024-10-16 22:53
Type: PHYSICIAN SURGERY PROGRESS NOTES
Author: MASSADI,MUSTAFA SABRI MUHIEDDIN
Location: KHCC-6H-PEDIATRIC
Service: INTERNAL MEDICINE
================================================================================

'
 

==========================

Neurosurgery Team Consult:

==========================

 

Primary Disease : B cell ALL

status post : off therapy on 12/12/2023

Chief Complain : Headache and high blood pressure 

 

- The patient presented to ER complaining of headache since 1 month that get 

  worse yesterday associated with photophobia also she has unsteady gait

- She has polyurea 

- no vomiting, no abdominal pain 

- Afebrile 

 

- she presented on 15/10 for the same complaint and found to be hypertense.

- Brain CT was done: No intracranial haemorrhage, midline shift or herniation. 

  Petent dual venous sinuses. 

 

But as Dr **********m **********soud there is brain stem new vascular lesion; 

so the plan will be:

Do Brain MRI with contrast.

 

No clearance for LP Before reviweing the MRI with official repor. 




================================================================================
Date: 2024-10-16 20:33
Type: PEDIATRIC PHYSICIAN PROGRESS NOTE
Author: ALHASAN,RAHAF JADEE BAKHEET
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
Pediatrics oncology oncall fellow admisison note.

 

 

**********aher Al********** is an 8 Year 9 months old ********** girl, case of low risk B cell 

ALL, completed therpay on 12/12/2023

 

Presented to clinic yesterday complaining of occasional milf headache frontal 

headache and limping since the past 2 weeks.

She also has elevated blood pressure readings(Accepatble upper limit for BP for 

her age and height 120/75). 

On the ED 145/100 so recived hydralazine 6mg

blood pressure before dishcrage: 126/94

Nephrology consult done; the plan was to assess her in nephrology OPC this 

Thursday.

 

 

O/E:

throat and chest clear

abdomen soft lax

she has lipming gait

Power 5/5 in all limbs.

Reflees +2.

Reactive pupils.

CBC HB 13.3 WBCS 6.6 N 37 L 56.9 plt 97.

Blood film was sent.

CT brain done : Unremarkable.

 

 

Today :

We informed about flowcytometry showed 8 % blast

 

She came to the ED with a new complaint : Nystagmus.

 

she is consious , oriented GCS 15/15

but she has wide base gait

and Left eye Nystagmus 

seen by opthalmologist , they reported papilledema

 

Received dexamethasone STAT 4 mg.

 

Neurology consult done;

Start Levetracetam 300 mg BID.

Start Acetozolamide 250 mg BID.

Do LP with opening pressure.

Follow up in the clinic.

 

 

Neurosurgury consult (Clearance for LP):

Recommended doing MRI brain and orbit prior to LP.

 

Nephrology consult:

Start amlodpine 2.5 mg once daily.

Do Renal doppler US.

OPC tomorrow.

 

 

Admitted to the floor for:

Monitoring her clinically and to monitor her BP.

MRI brain and orbit tomorrow.

BM and TIT tomorrow (If cleared from neurosurgery)

Daily CBC and chemistry and VBG.

 




================================================================================
Date: 2024-10-16 19:56
Type: PHYSICIAN ANESTHESIA RECORD
Author: ENIEZAT,HAMZA HUSNI ALI
Location: KHCC-6H-PEDIATRIC
Service: ANESTHESIOLOGY/PAIN MANAGEMENT
================================================================================

'
--------------------------------------------------------------------------------

                          Pre-Anesthesia evaluation 

--------------------------------------------------------------------------------

Age:8yr **********mo Gender FEMALE 

Evaluation done as: Inpatient

 

---------------------------------Vital signs------------------------------------

98.4 F [36.9 C] (10/16/2024 18:10)138 (10/16/2024 18:10)

10/16/24 @ 1810     PULSE OXIMETRY: 95

Height:52.756 in [134.0 cm] (10/16/2024 18:10)

BODY MASS INDEX - 19.3 (OCT 16, 2024@18:10:09)

--------------------------------------------------------------------------------

Procedure:   MRI

 

Surgeon name:

--------------------------------------------------------------------------------

Diagnosis:ALL

--------------------------------------------------------------------------------

the patient has been reevaluated for MRI under GA 

she is a known case of ALL and was admitted cuz of high BP and tachycardia 

138/99  ,pulse 138, A-febrile 

 

labs acceptable 

plane

to keep her BP under control , 

proceed if still stable 




================================================================================
Date: 2024-10-16 19:11
Type: PHYSICIAN PEDIATRIC ADMISSION NOTES
Author: MUQBEL,ROA ABDUL RAZZAQ KHALIL
Location: KHCC-6H-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
patient name:**********  patient ID:**********

patient age:**********yr **********mo    patient DOP:**********

patient sex:FEMALE    Date: Oct 16,2024 

--------------------------------------------------------------------------------

                          Pediatric Admission Note

--------------------------------------------------------------------------------

-----------------------------Initial Assessment---------------------------------

Vital Sings

RESPIRATION:    24 (10/16/2024 18:10)

BLOOD PRESSURE :138/99 (10/16/2024 18:10)

PULSE:          138 (10/16/2024 18:10)

PULSE OXIMETRY: 10/16/24 @ 1810     PULSE OXIMETRY: 95

TEMPERATURE:    98.4 F [36.9 C] (10/16/2024 18:10)

B.S.A:          BSA -  1.13

patient Hight:52.756 in [134.0 cm] (10/16/2024 18:10) 

patient weight: 76.06 lb [34.6 kg] (10/16/2024 18:10)

--------------------------------------------------------------------------------

Allergy:Patient has answered NKA

--------------------------------------------------------------------------------

Problems:

Active problems - Computerized Problem List is the source for the following:

 

 1. Leukemia, Lymphocytic                             02/06/22  MSAMEH,ALAA YOUS

 2. Syrian refugee                                    02/06/22  ZANDAKI,DUAA AHM

 3. sever vomiting after anesthesia                   05/25/21  ALSHATHLY,MUHANA

 4. delayed MTX excretion                             05/25/21  ALSHATHLY,MUHANA

 5. Pancytopenia                                      02/06/22  HAJJIR,HALA AHMA

 6. septic shock ICU admission                        11/14/21  GUZU,TASNEEM ALI

 7. TBNK flow: low                                    02/06/22  BUDAIR,RAWAN NOU

 8. chemosensitivity for workup                       04/03/22  ZANDAKI,DUAA AHM

--------------------------------------------------------------------------------

Chief Complaint:suspected relapse ( headache , ataxia )

 

--------------------------------------------------------------------------------

Present Illness:

----------------

- ********** year old female patient , case of B cell ALL

- status post: off therapy on 12/12/2023

 

on 15/10:

- she presented to ER with headache since 1 month that got 

worse today associated with photophobia and unsteady gait. She also has polyurea

 

but no vomiting ,no abdominal pain. She is Afebrile 

- she was found to be hypertense , Brain CT was done:No intracranial 

haemorrhage, midline shift or herniation, Petent dual venous sinuses.

- she was given hydralazine and nephrology consulted :no need to start 

antihypertensive medication to follow up in clinic 

- Blood film was sent showed :8 % blast

 

Today :

- re-presented to ER with same complain 

 

-----------------Review of Systems (Give details and negatives)-----------------

headache since 1 month associated with photophobia and unsteady gait. She also 

has polyurea 

 

-No fever, No chills/rigors. 

-No hypoactivity, no change in oral intake

-No runny nose, no cough, no SOB, no sorethroat, no ear pain.

-No vomiting, no abdominal pain. No chnage in bowel habits. 

-No urinray symptoms. No flank pain. 

-No history of sick contacts

 

--------------------------------------------------------------------------------

Developmental History: up to age

 

Immunizations: Up to age

 

Allergy: no allergies

 

Past Medical/Neonatal history:

Normal vaginal delivery, entered NICU for respiratory distress.

 

Past Surgical History: free

 

Current Medications:

- gabapentin 300 BID

 

Family History/Pedigree:

- she has 2 brothers and 2 sisters , and 1 Brother died due to sudden infant 

death syndrome at 9 months.

- No consanguinity between parents

- grandfather died from laryngeal cancer

 

Psychosocial History: 

- Syrian refugee, They live in **********qaa 

 

----------------------------Physical Examination--------------------------------

- there is sluggish left pupil , limitation in eye movement , multidirectional 

nystagmus , wide based gait , ataxic , can't do tandem gait 

 

-HNNET: No conjunctival pallor, No jaundice, No mouth ulcers, No lymphadenopathy

-Chest: No use of accessory muscles, GAEBL, No wheezes, No crackles 

-Cardiovascular: Normal S1, S2, No murmurs, No added sounds.

-Abdomen: Not distended, soft , no rigidity, no gaurding 

-Skin: No skin lesions, no rash/ petichiae.

 

------------------------------Laboratory Tests----------------------------------

as below

 

---------------------------------X-Rays-----------------------------------------

Brain CT 15/10 - pending report

 

Brain and orbit MRI today : FREE AS PRIMARY READING

 

--------------------------------------------------------------------------------

                          VTE risk factors

--------------------------------------------------------------------------------

Patient Age < 10 years:NA

--------------------------------Assessment--------------------------------------

 

- ********** year old female patient , case of B cell ALL

- status post: off therapy on 12/12/2023

 

on 15/10:

- she presented to ER with headache since 1 month that got 

worse today associated with photophobia and unsteady gait. She also has polyurea

 

but no vomiting ,no abdominal pain. She is Afebrile 

- she was found to be hypertense , Brain CT was done:No intracranial 

haemorrhage, midline shift or herniation, Petent dual venous sinuses.

- she was given hydralazine and nephrology consulted :no need to start 

antihypertensive medication to follow up in clinic 

- Blood film was sent showed :8 % blast

 

Today :

- re-presented to ER with same complain 

 

on exam:

--------

- there is sluggish left pupil , limitation in eye movement , multidirectional 

nystagmus , wide based gait , ataxic , can't do tandem gait 

 

 

Consults:

---------

- Opthalmology -> left eye exotropia + limitation on adduction , 

                  has papilledema- treat her increased ICP- 

                  do Brain + Orbit Mri to rule out brain versus orbital 

                  leukemic infiltrtaion is needed

                  diamox dose + steroid is recommended to decrease 

                  intracranial pressure utill the underlying cause resolve 

 

- Nephrology consulted -> start on amlodipine 2.5mg Qday 

                          Renal U/S tomorrow 

 

Medications:

------------

-recieved perflgan , Hydralazine and dexamethasone 4 mg

 => her headache improved 

 

 

Labs:

-----

- CBC : hemoglobin 13.3 , WBC 6.6 , platlets 97 , ANC 2400

- vChesmitry : normal

 

 

so she was admitted to floor on keppra 300 mg*2, diamox 250mg*2 , amlodipine 

2.5mg Qday

 

Brain and orbit MRI done after admission  : FREE AS PRIMARY READING

 

------------------------------Plan of Care--------------------------------------

- send venous blood gases as a baseline befor starting on diamox

- Anasthesia consult

- Neurosurgury consult before Lumbar puncture :

if clearance given from neurosurgury , do Bone marrow aspiration and biopsy plus

 

lumbar puncture with opening pressure tomorrow morning

if Not cleared so to do Bone marrow only and send analysis , cytology , TdT , if

 

her clinical status allow.

- Abdomial and renal U/S and ECHO

- neurology consult and start keppra prophylaxis .

- Daily CBC and chemistry.

 

------------------------------Consultation--------------------------------------

as above

+ anesthesia consult : fit for anesthesia

 

=================================Discharge planning note========================

Reason of admission: suspected relapse

 

Estimated length of stay:5 days

 

Goals of Care/needed interventions:

Consult, Radiology

 

Special Needs upon Discharge

No Special needs

 

Delayed discharge

No




================================================================================
Date: 2024-10-16 19:10
Type: PHYSICIAN ANESTHESIA RECORD
Author: ENIEZAT,HAMZA HUSNI ALI
Location: KHCC-6H-PEDIATRIC
Service: ANESTHESIOLOGY/PAIN MANAGEMENT
================================================================================

'
--------------------------------------------------------------------------------

                          Pre-Anesthesia evaluation 

--------------------------------------------------------------------------------

Age:8yr **********mo Gender FEMALE 

Evaluation done as: Inpatient

 

---------------------------------Vital signs------------------------------------

98.4 F [36.9 C] (10/16/2024 18:10)138 (10/16/2024 18:10)

10/16/24 @ 1810     PULSE OXIMETRY: 95

Height:52.756 in [134.0 cm] (10/16/2024 18:10)

BODY MASS INDEX - 19.3 (OCT 16, 2024@18:10:09)

--------------------------------------------------------------------------------

Procedure:   MRI

 

Surgeon name:

--------------------------------------------------------------------------------

Diagnosis:

--------------------------------------------------------------------------------

the patient has been evaluated for MRI under GA 

the patient and her father state that she want to do the procedure without 

anesthesia . 




================================================================================
Date: 2024-10-16 17:40
Type: INTERDISCIPLINARY FAMILY/PATIENT EDUCATION NOTE
Author: ABUODEH,NOUR TAYSEER MOHAMMAD
Location: KHCC-6H-PEDIATRIC
Service: NURSING
================================================================================

'
patient name:**********  patient ID:**********

patient age:**********yr **********mo    patient DOP:**********

patient sex:FEMALE    patient location:WARD LOC - **********C-6H-PEDIATRIC

--------------------------------------------------------------------------------

                 INTERDISCIPLINARY PATIENT/FAMILY EDUCATION

--------------------------------------------------------------------------------

Wellingness to Learn : Yes

 

LEARNING BARRIERS (please mark the learning Barrier available)

L Other / Specify Age specific

 

 

Identify patient learning needs (mark the need)

Patient's rights and Responsibilities, Modification of life style / 

*Information taught*

--------------------------------------------------------------------------------

1. Patients rights and responsibilities 

Date:Oct 16,2024,Who was taught:Father 

Tools:Oral,Barriers:L

 

patient's father educated about Patients rights and responsibilities at 

admissioin office...

 

Patient understanding Evaluation/Comments:

Verbalizes basic concepts with assistance

--------------------------------------------------------------------------------

5. Daily activites, safe and effective use of equipment, exercise and/or 

rehabilitation technique

Date:Oct 16,2024,Who was taught:Father 

Tools:Oral,Barriers:L

 

patient's father educated about falling down precaution as newly admission 

patient, that many things can lead to falls, most often when the patient try 

to get up or walk without assistance especially in night, so there is some 

steps patient and family must follow to prevent falling down started with 

waiting for assistance or call for help before getting up especially if 

patient feels dizzy ,drowsy, fatigue, and don't walk in socks alone or without 

shoes to avoid sliding and take a look around and make sure that there is no 

lines connected to the patient, go slow and take a moment when reach the 

sitting position before standing up to avoid dizziness, and turn the lights on 

before getting up ,if child have glasses make sure to wear it  before 

standing, try to use assistive devices as directed, also while the patient in 

bed , make sure to maintain bed at the lowest level and keep side rails up...

 

finally if the child has history of falling down the health care provider must 

informed , and if any accident happened too...

 

patient's father was interested in listening to my instructions and understand 

it completely...

 

Patient understanding Evaluation/Comments:

Verbalizes basic concepts with assistance

 




================================================================================
Date: 2024-10-16 17:09
Type: PEDIATRIC PHYSICIAN PROGRESS NOTE
Author: ALHASAN,RAHAF JADEE BAKHEET
Location: EMERGENCY-KS-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
Pediatrics oncology fellow admission note.

 

 

********** years old female, case of treated B-ALL, off therapy since 

December/2023.

 

Has headache and ataxia since 1 month.

 

Brain CT:

No acute insult.

 

Blood film:

8%.

 

Eye examiantion:

Paipilloedema.

 

Impression:

Combined BM and CNS mets.

 

Reason of consultation:

Clearance prior to doing LP.

 




================================================================================
Date: 2024-10-16 16:53
Type: PHYSICIAN OUT PATIENT FOLLOW UP NOTE
Author: AHMED,HIBA EMADELDEEN ABDELSAMAD
Location: LEUK-PED-RAWAD RIHANI
Service: INTERNAL MEDICINE
================================================================================

'
 

Fellow on service Note :

 

**********aher Al********** is an 8 Year 9 months old ********** girl, case of low risk B cell 

ALL, completed therpay on 12/12/2023

 

Presented to clinic yesterday with her fater

complain of severe lower limb pain

polyuria and polydepsia

Abnormal behaviour as she washed her hands many times at clinic as she feel 

hotness

Also she has fluctuating blood pressure

yesterday she looked in pain , and she was anxious 

consious , oriented GCS 15/15

10/15/24

14:43

    P:   144

    B/P: 132/92*

    Pulse Oximetry: 99%

12:47

    T:   98.6 F (37.0 C)

    P:   102

    B/P: 128/80*

    Pulse Oximetry: 99%

throat and chest clear

abdomen soft lax

she has lipming gait

Unremarkable neurological exam

CBC HB 13.3 WBCS 6.6 N 37 L 56.9 plt 97

We sent her to ER For pain and Bp control and urgent imaging.

 

AT ER Yesterday evening :

During ER, her blood pressure reach to 145/100 so recived hydralazine 6mg

blood pressure before dishcrage: 126/94

resolved headache and bony pain with perfelgan

CT brain primary reading is unremarkable

 

Today :

We informed about flowcytometry showed 8 % blast

I assessed her at ER

she is consious , oriented GCS 15/15

but she has wide base gait

and Left eye Nystagmus 

seen by opthalmologist , they reported papilledema

 

Plan :

- To start her on Acetazolamide

- give one dose of iv dexamethasone 

- Anasthesia consult

- Neurosurgury consult before Lumbar puncture :

if clearance given from neurosurgury , do Bone marrow aspiration and biopsy plus

 

lumbar puncture with opening pressure tomorrow morning

if Not cleared so to do Bone marrow only and send analysis , cytology , TdT , if

 

her clinical status allow.

- Abdomial U/S and ECHO

- Brain and orbit MRI .

- neurology consult and start keppra prophylaxis .

- Daily CBC and chemistry .

 

Primary doctor and attending oncall both informed .




================================================================================
Date: 2024-10-16 16:43
Type: PHYSICIAN OUT PATIENT FOLLOW UP NOTE
Author: DARWEESH,RAGHAD MAHMOUD ALI
Location: EMERGENCY-KS-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
EMERGENCY FOLLOW UP NOTE :

===========================

I handed the patient from the day resident 

 

 

- RECEIVED PERFALGAN, HYDRLAZINE, AND DEXA 4 mg

16:42

     B/P: 132/93*

 

 

- her headache improved 

 

plan of care :

==============

- will be admitted on keppra 300 mg*2, diamox 250mg*2 , amlodipine 2.5mg Qday

- send vbg now as a baseline befor starting on diamox

- Anasthesia consult

- Neurosurgury consult before Lumbar puncture :

if clearance given from neurosurgury , do Bone marrow aspiration and biopsy plus

 

lumbar puncture with opening pressure tomorrow morning

if Not cleared so to do Bone marrow only and send analysis , cytology , TdT , if

 

her clinical status allow.

- Abdomial and renal U/S and ECHO

- Brain and orbit MRI .

- neurology consult and start keppra prophylaxis .

- Daily CBC and chemistry.




================================================================================
Date: 2024-10-16 15:49
Type: PHYSICIAN OPHTHALMOLOGY ONCOLOGY NOTE
Author: SOUDI,RAMA SULIMAN ISMAIL
Location: OCULAR ONC-YACOUB YUSEF
Service: INTERNAL MEDICINE
================================================================================

'
 

Zaher Al-********** is an ********** Year old girl a case of low risk B cell ALL

 

status post: off therpay on 12/12/2023

 

In ER:

======

-did brain CT with contrast: unremarkble

 

--------------------------------------------

 

History Of Eye Surgery:none

 

Complaint:left eye outward deviation - headache on and off-unsteady gate since 

one month

 

Ophthalmic Examination:

Vision sc: OD 0.8

           OS 0.8

 

Pupil:No RAPD

Alignment:Left eye exotropia

Extraocular Motility:Left eye mild limitation on adduction

 

Anterior Segment:

cornea clear

lens clear

ac deep and quite

 

Fundus Exam: 

bilateral optic disc swelling

normal macula ou

flat retina

 

OCT ONH was done

bilateral papilledma confirmed on oct onh

 

Impression + plan

left eye exotropia + limitation on adduction 

papilledema- treat her increased ICP- Brain + Orbit Mri to rule out brain vs 

orbital leukemic infiltrtaion is needed

diamox dose + steroid is recommended to decrease intracranial pressure till you 

resolve the underlying cause

 

 

      RTC:1 week 

 




================================================================================
Date: 2024-10-16 15:03
Type: PHYSICIAN PAIN CLINIC -PEDIATRIC
Author: BANI MUSTAFA,AMAL MUSTAFA AHMAD
Location: EMERGENCY-KS-PEDIATRIC
Service: PEDIATRICS/HEMATOLOGY
================================================================================

'
patient name:**********  patient ID:**********

patient age:8yr **********mo    patient DOP:**********

patient sex:FEMALE 

--------------------------------------------------------------------------------

                             Pediatric Pain Clinic

--------------------------------------------------------------------------------

Allergy:ALLERGIES/ADVERSE REACTIONS - NONE FOUND

 

--------------------------------------------------------------------------------

VITALS:

  DATE/TIME         TEMP    PULSE   RESP    BP      PAIN    WT (LB) P OX 

10/16/24 @ 1442     97.3    116     21      122/98  4               96 

Height:Refused (10/15/2024 15:28)

--------------------------------------------------------------------------------

Diagnosis:

Active problems - Computerized Problem List is the source for the following:

 

 1. Leukemia, Lymphocytic

 2. Syrian refugee

 3. sever vomiting after anesthesia 

 4. delayed MTX excretion

 5. Pancytopenia

 6. septic shock ICU admission 

 7. TBNK flow: low

 8. chemosensitivity for workup

 

Code status:Full code

Type of visit:Follow up visit

Duration of pain:Acute

Somatic/Visceral,Site:bony pain and headache 

Neuropathic,Site:yes

Description of pain:hotness in her bilateral hands 

 

Duration:3 weeks 

 

Pain scale:  /10 According to:NRS

----------------------------------------------------------------------

**********aher is ********** years old , known case of B-ALL.

-S/P: off therapy since 12/23

-cause of consult : bilateral wrist pain and hotness

                    she started to have headache ,sever in nature 

-duration : 2weeks 

 

ZAHER ALSHAM transfered to ER due to sever headache ,WE HAVE PHONED HER 

GRANDFATHER BY PHONE 

she has new onset of unsteady gait and hotness of bilateral hands 

 

 

medications:

-------------

-start gabapentin 300mg po bid .

-paracetmol PRN . 

 

 

plan:

-----

**********eeep SAME MEDICATIONS 

 




================================================================================
Date: 2024-10-16 15:01
Type: EMERGENCY PHYSICIAN NOTE (ADULT & PEDIATRIC PATIENTS)
Author: ABU-AJAMIEH,LAMA KHALID TAHA
Location: EMERGENCY-KS-PEDIATRIC
Service: INTERNAL MEDICINE
================================================================================

'
--------------------------------------------------------------------------------

                        Emergency Physicians Note

--------------------------------------------------------------------------------

 

Arrival Date and Time: Oct 16,2024

Time of Assissment:Oct 16,2024@15:01

Means of arrival: Walk-In

Source of information: father

Emergency Care/Medications given prior to ER arrival:

-

Primary Disease:B cell ALL

status post: off therapy on 12/12/2023

Chief Complain: Headache and high blood pressure 

Vital Signs: 

  DATE/TIME         TEMP    PULSE   RESP    BP      PAIN    WT (LB) P OX 

10/16/24 @ 1442     97.3    116     21      122/98  4               96 

Allergy History:Patient has answered NKA

=======================Hx of presen Illness===========================

-The patient presented to ER complaining of headache since 1 month that get 

worse yesterday associated with photophobia 

also she has unsteady gait

-She has polyurea 

-no vomiting ,no abdominal pain 

-Afebrile 

 

->>she presented on 15/10 for the same complaint and found to be hypertense

-Brain CT was done:No intracranial haemorrhage, midline shift or herniation. 

Petent dual venous sinuses 

-she was given hydralazine and nephrology consulted :no need to start 

antihypertensive medication to follow up in clinic 

-Blood film was done showed :8 % blast

 

=======================Past Medical History===========================

 

free

=======================Past Surgical History===========================

free

 

=========Home Medication and medication given before arrival==========

 

gabapentin 300mg bid .

 

===========================Physical Exam==============================

 

PHYSICAL EXAMINATION : 

-General: Conscious, Alert, Oriented,in pain 6/10

-HEENT: No cervical lymphoadenopathy, Wet mucuos mambranes, No tonsillar 

erythema or exudate 

-Respiratory: Good equal air entey bilaterally, No whezees, No crepitations-

-Abdomen: Soft, lax, No tenderness, No distention 

-Skin: No rashes 

-Neuroexam:GCS:15/15

NORMAL SPEECH

INTACT SENSATIONS

Normal power 

limitation in eye movements

there is slugish left pupil

multidirectional nystagmus 

wide based gait 

ataxic 

can't do tandem gait 

negative meningeal sign 

 

============================Plan of Care==============================

Labs:-

Radiology:-

Medication:hydralazine and perflgan 

Consultation:opthalmology ,nephrology 

Procedures:-

=======================Assessment and Conclusion===========================

-The patient presented to ER complaining of headache since 1 month that get 

worse yesterday associated with photophobia 

also she has unsteady gait

-She has polyurea 

-no vomiting ,no abdominal pain 

-Afebrile 

 

->>she presented on 15/10 for the same complaint and found to be hypertense

-Brain CT was done:No intracranial haemorrhage, midline shift or herniation. 

Petent dual venous sinuses 

-she was given hydralazine and nephrology consulted :no need to start 

antihypertensive medication to follow up in clinic 

-Blood film was done showed :8 % blast

 

 

in ER

 

vitals

10/16/24

14:42

    T:   97.3 F (36.3 C)

    P:   116

    R:   21

    B/P: 122/98*

    Pulse Oximetry: 96%

    Pain: 4

 

Dr **********af ,Dr ********** and I assessed the patient 

 

on exam:

there is slugish left pupil

limitation in eye movement 

multidirectional nystagmus 

wide based gait 

ataxic 

can't do tandem gait 

 

 

-Opthalmology consulted -> 

left eye exotropia + limitation on adduction 

papilledema- treat her increased ICP- Brain + Orbit Mri to rule out brain vs 

orbital leukemic infiltrtaion is needed

diamox dose + steroid is recommended to decrease intracranial pressure till you 

resolve the underlying cause

 

-Nephrology consulted ->start on amlodipine 2.5mg Qday 

Renal U/S tomorrow 

Follow up in clinic tomorrow 

 

-Will recieve perflgan and Hydralazine 

 

-The patient was handed over to oncall resident to follow up on:

->Headache and Blood pressure reading after the medication 

->consult neurology 

->plan 